Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
alprazolam | [no description available] | medium | 1 | 0 | organochlorine compound; triazolobenzodiazepine | anticonvulsant; anxiolytic drug; GABA agonist; muscle relaxant; sedative; xenobiotic |
amiodarone | [no description available] | medium | 2 | 0 | 1-benzofurans; aromatic ketone; organoiodine compound; tertiary amino compound | cardiovascular drug |
amitriptyline | [no description available] | medium | 1 | 0 | carbotricyclic compound; tertiary amine | adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic |
bupivacaine | [no description available] | medium | 1 | 0 | aromatic amide; piperidinecarboxamide; tertiary amino compound | |
carbamazepine | [no description available] | medium | 1 | 0 | dibenzoazepine; ureas | analgesic; anticonvulsant; antimanic drug; drug allergen; EC 3.5.1.98 (histone deacetylase) inhibitor; environmental contaminant; glutamate transporter activator; mitogen; non-narcotic analgesic; sodium channel blocker; xenobiotic |
carteolol | [no description available] | medium | 1 | 0 | quinolone; secondary alcohol | anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist; sympatholytic agent |
chlorzoxazone | [no description available] | medium | 7 | 0 | 1,3-benzoxazoles; heteroaryl hydroxy compound; organochlorine compound | muscle relaxant; sedative |
citalopram | [no description available] | medium | 1 | 0 | 2-benzofurans; cyclic ether; nitrile; organofluorine compound; tertiary amino compound | |
dapsone | [no description available] | medium | 1 | 0 | substituted aniline; sulfone | anti-inflammatory drug; antiinfective agent; antimalarial; leprostatic drug |
felodipine | [no description available] | medium | 1 | 0 | dichlorobenzene; dihydropyridine; ethyl ester; methyl ester | anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent |
fentanyl | [no description available] | medium | 2 | 0 | anilide; monocarboxylic acid amide; piperidines | adjuvant; anaesthesia adjuvant; anaesthetic; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic |
flunitrazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes | anxiolytic drug; GABAA receptor agonist; sedative |
haloperidol | [no description available] | medium | 1 | 0 | aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol | antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist |
imipramine | [no description available] | medium | 3 | 0 | dibenzoazepine | adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
omeprazole | [no description available] | medium | 3 | 0 | aromatic ether; benzimidazoles; pyridines; sulfoxide | |
pimobendan | [no description available] | medium | 1 | 0 | benzimidazoles; pyridazinone | cardiotonic drug; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; vasodilator agent |
terfenadine | [no description available] | medium | 2 | 0 | diarylmethane | |
troglitazone | [no description available] | medium | 2 | 0 | chromanes; thiazolidinone | anticoagulant; anticonvulsant; antineoplastic agent; antioxidant; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; hypoglycemic agent; platelet aggregation inhibitor; vasodilator agent |
venlafaxine | [no description available] | medium | 1 | 0 | cyclohexanols; monomethoxybenzene; tertiary alcohol; tertiary amino compound | adrenergic uptake inhibitor; analgesic; antidepressant; dopamine uptake inhibitor; environmental contaminant; serotonin uptake inhibitor; xenobiotic |
colchicine | [no description available] | medium | 4 | 0 | alkaloid; colchicine | anti-inflammatory agent; gout suppressant; mutagen |
bromodichloromethane | [no description available] | medium | 1 | 0 | halomethane | environmental contaminant; reagent |
erythromycin | [no description available] | medium | 2 | 0 | cyclic ketone; erythromycin | |
vinblastine | [no description available] | medium | 4 | 0 | | |
pimozide | [no description available] | medium | 1 | 0 | benzimidazoles; heteroarylpiperidine; organofluorine compound | antidyskinesia agent; dopaminergic antagonist; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist |
1-nitropyrene | [no description available] | medium | 1 | 0 | nitroarene | carcinogenic agent |
paclitaxel | [no description available] | medium | 5 | 0 | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
etoposide | [no description available] | medium | 1 | 0 | beta-D-glucoside; furonaphthodioxole; organic heterotetracyclic compound | antineoplastic agent; DNA synthesis inhibitor |
adinazolam | [no description available] | medium | 1 | 0 | triazolobenzodiazepine | anticonvulsant; antidepressant; anxiolytic drug; sedative |
diltiazem | [no description available] | medium | 1 | 0 | 5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | antihypertensive agent; calcium channel blocker; vasodilator agent |
simvastatin | [no description available] | medium | 1 | 0 | delta-lactone; fatty acid ester; hexahydronaphthalenes; statin (semi-synthetic) | EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor; ferroptosis inducer; geroprotector; prodrug |
mifepristone | [no description available] | medium | 1 | 0 | 3-oxo-Delta(4) steroid; acetylenic compound; tertiary amino compound | abortifacient; contraceptive drug; hormone antagonist; synthetic oral contraceptive |
zileuton | [no description available] | medium | 2 | 0 | 1-benzothiophenes; ureas | anti-asthmatic drug; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; ferroptosis inhibitor; leukotriene antagonist; non-steroidal anti-inflammatory drug |
irinotecan | [no description available] | medium | 1 | 0 | carbamate ester; delta-lactone; N-acylpiperidine; pyranoindolizinoquinoline; ring assembly; tertiary alcohol; tertiary amino compound | antineoplastic agent; apoptosis inducer; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug |
tazofelone | [no description available] | medium | 1 | 0 | | |
clarithromycin | [no description available] | medium | 3 | 0 | macrolide antibiotic | antibacterial drug; environmental contaminant; protein synthesis inhibitor; xenobiotic |
docetaxel | [no description available] | medium | 1 | 0 | hydrate; secondary alpha-hydroxy ketone | antineoplastic agent |
taurochenodeoxycholic acid | [no description available] | medium | 1 | 0 | bile acid taurine conjugate | human metabolite; mouse metabolite |
ritonavir | [no description available] | medium | 1 | 0 | 1,3-thiazoles; carbamate ester; carboxamide; L-valine derivative; ureas | antiviral drug; environmental contaminant; HIV protease inhibitor; xenobiotic |
saquinavir | [no description available] | medium | 1 | 0 | L-asparagine derivative; quinolines | antiviral drug; HIV protease inhibitor |
tacrolimus | [no description available] | medium | 1 | 0 | macrolide lactam | bacterial metabolite; immunosuppressive agent |
tamoxifen | [no description available] | medium | 1 | 0 | stilbenoid; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator |
quinine | [no description available] | medium | 1 | 0 | cinchona alkaloid | antimalarial; muscle relaxant; non-narcotic analgesic |
senecionine | [no description available] | medium | 1 | 0 | lactone; pyrrolizidine alkaloid; tertiary alcohol | plant metabolite |
cyclosporine | [no description available] | medium | 1 | 0 | homodetic cyclic peptide | anti-asthmatic drug; anticoronaviral agent; antifungal agent; antirheumatic drug; carcinogenic agent; dermatologic drug; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; geroprotector; immunosuppressive agent; metabolite |
sirolimus | [no description available] | medium | 1 | 0 | antibiotic antifungal drug; cyclic acetal; cyclic ketone; ether; macrolide lactam; organic heterotricyclic compound; secondary alcohol | antibacterial drug; anticoronaviral agent; antineoplastic agent; bacterial metabolite; geroprotector; immunosuppressive agent; mTOR inhibitor |
onapristone | [no description available] | medium | 1 | 0 | | |
indinavir sulfate | [no description available] | medium | 1 | 0 | dicarboxylic acid diamide; N-(2-hydroxyethyl)piperazine; piperazinecarboxamide | HIV protease inhibitor |
zatosetron | [no description available] | medium | 1 | 0 | | |
k11002 | [no description available] | medium | 1 | 0 | | |
vindesine | [no description available] | medium | 1 | 0 | | |
lilopristone | [no description available] | medium | 1 | 0 | | |
clozapine | [no description available] | medium | 1 | 0 | benzodiazepine; N-arylpiperazine; N-methylpiperazine; organochlorine compound | adrenergic antagonist; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; GABA antagonist; histamine antagonist; muscarinic antagonist; second generation antipsychotic; serotonergic antagonist; xenobiotic |
rifabutin | [no description available] | medium | 1 | 0 | | |
chloroquine diphosphate | [no description available] | medium | 1 | 0 | | |
coumarin | [no description available] | medium | 11 | 0 | coumarins | fluorescent dye; human metabolite; plant metabolite |
herniarin | [no description available] | medium | 4 | 0 | coumarins | fluorochrome |
coumarin-3-carboxylic acid | [no description available] | medium | 1 | 0 | coumarins | |
7-methoxy-2-oxo-1-benzopyran-3-carboxylic acid ethyl ester | [no description available] | medium | 1 | 0 | coumarins | |
propranolol | [no description available] | medium | 8 | 0 | naphthalenes; propanolamine; secondary amine | anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic |
vinorelbine | [no description available] | medium | 3 | 0 | acetate ester; methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; ring assembly; vinca alkaloid | antineoplastic agent; photosensitizing agent |
fosbretabulin | [no description available] | medium | 3 | 0 | stilbenoid | |
mannitol | [no description available] | medium | 2 | 0 | mannitol | allergen; antiglaucoma drug; compatible osmolytes; Escherichia coli metabolite; food anticaking agent; food bulking agent; food humectant; food stabiliser; food thickening agent; hapten; metabolite; osmotic diuretic; sweetening agent |
7-hydroxycoumarin | [no description available] | medium | 49 | 0 | hydroxycoumarin | fluorescent probe; food component; plant metabolite |
pexacerfont | [no description available] | medium | 1 | 0 | pyrazolopyridine | |
carbonyl cyanide m-chlorophenyl hydrazone | [no description available] | medium | 1 | 0 | hydrazone; monochlorobenzenes; nitrile | antibacterial agent; geroprotector; ionophore |
celecoxib | [no description available] | medium | 2 | 0 | organofluorine compound; pyrazoles; sulfonamide; toluenes | cyclooxygenase 2 inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
indomethacin | [no description available] | medium | 1 | 0 | aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole | analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic |
cysteine | [no description available] | medium | 1 | 0 | cysteine zwitterion; cysteine; L-alpha-amino acid; proteinogenic amino acid; serine family amino acid | EC 4.3.1.3 (histidine ammonia-lyase) inhibitor; flour treatment agent; human metabolite |
hyperforin | [no description available] | medium | 1 | 0 | | |
l 663536 | [no description available] | medium | 1 | 0 | aryl sulfide; indoles; monocarboxylic acid; monochlorobenzenes | antineoplastic agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; leukotriene antagonist |
ys 121 | [no description available] | medium | 1 | 0 | medium-chain fatty acid | |
ascorbic acid | [no description available] | medium | 1 | 0 | ascorbic acid; vitamin C | coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent |
agelastatin a | [no description available] | medium | 1 | 0 | | |
fludarabine | [no description available] | medium | 1 | 0 | purine nucleoside | |
4-methylumbelliferyl acetate | [no description available] | medium | 1 | 0 | acetate ester; coumarins | plant metabolite |
theophylline | [no description available] | medium | 4 | 0 | dimethylxanthine | adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent |
scoparone | [no description available] | medium | 1 | 0 | aromatic ether; coumarins | anti-allergic agent; anti-inflammatory agent; antihypertensive agent; antilipemic drug; immunosuppressive agent; plant metabolite |
4-methyl-7-ethoxycoumarin | [no description available] | medium | 3 | 0 | coumarins | |
7-methoxy-4-methyl-1-benzopyran-2-one | [no description available] | medium | 1 | 0 | coumarins | |
7-acetoxycoumarin | [no description available] | medium | 1 | 0 | | |
hymecromone | [no description available] | medium | 2 | 0 | hydroxycoumarin | antineoplastic agent; hyaluronic acid synthesis inhibitor |
esculetin | [no description available] | medium | 1 | 0 | hydroxycoumarin | antioxidant; plant metabolite; ultraviolet filter |
oxophenylarsine | [no description available] | medium | 1 | 0 | arsine oxides | antineoplastic agent; apoptosis inducer; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor |
warfarin | [no description available] | medium | 279 | 0 | benzenes; hydroxycoumarin; methyl ketone | |
ciprofloxacin | [no description available] | medium | 2 | 0 | aminoquinoline; cyclopropanes; fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone; zwitterion | antibacterial drug; antiinfective agent; antimicrobial agent; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; environmental contaminant; topoisomerase IV inhibitor; xenobiotic |
ciprofloxacin-7-ethylenediamine | [no description available] | medium | 1 | 0 | | |
a 195773 | [no description available] | medium | 1 | 0 | macrolide antibiotic; monosaccharide derivative; quinolines | antibacterial drug; protein synthesis inhibitor |
zithromax | [no description available] | medium | 1 | 0 | macrolide antibiotic | antibacterial drug; environmental contaminant; xenobiotic |
hmr 3647 | [no description available] | medium | 2 | 0 | | |
a-130a | [no description available] | medium | 1 | 0 | | |
aurapten | [no description available] | medium | 3 | 0 | coumarins; monoterpenoid | antihypertensive agent; antineoplastic agent; antioxidant; apoptosis inducer; dopaminergic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; gamma-secretase modulator; gastrointestinal drug; hepatoprotective agent; matrix metalloproteinase inhibitor; neuroprotective agent; plant metabolite; PPARalpha agonist; vulnerary |
4'-geranyloxyferulic acid | [no description available] | medium | 1 | 0 | | |
buparlisib | [no description available] | medium | 1 | 0 | aminopyridine; aminopyrimidine; morpholines; organofluorine compound | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor |
gdc 0941 | [no description available] | medium | 1 | 0 | indazoles; morpholines; piperazines; sulfonamide; thienopyrimidine | EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor |
gdc 0980 | [no description available] | medium | 1 | 0 | | |
pki 587 | [no description available] | medium | 1 | 0 | | |
atenolol | [no description available] | medium | 2 | 0 | ethanolamines; monocarboxylic acid amide; propanolamine | anti-arrhythmia drug; antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; sympatholytic agent; xenobiotic |
verapamil | [no description available] | medium | 2 | 0 | aromatic ether; nitrile; polyether; tertiary amino compound | |
sulfaphenazole | [no description available] | medium | 3 | 0 | primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor |
alpha-naphthoflavone | [no description available] | medium | 8 | 0 | extended flavonoid; naphtho-gamma-pyrone; organic heterotricyclic compound | aryl hydrocarbon receptor agonist; aryl hydrocarbon receptor antagonist; EC 1.14.14.14 (aromatase) inhibitor |
talinolol | [no description available] | medium | 1 | 0 | ureas | |
quinidine | [no description available] | medium | 3 | 0 | cinchona alkaloid | alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker |
ketoconazole | [no description available] | medium | 2 | 0 | cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine | |
gdc 0449 | [no description available] | medium | 1 | 0 | benzamides; monochlorobenzenes; pyridines; sulfone | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist; teratogenic agent |
diazepam | [no description available] | medium | 8 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; environmental contaminant; sedative; xenobiotic |
furafylline | [no description available] | medium | 1 | 0 | oxopurine | |
propantheline bromide | [no description available] | medium | 1 | 0 | xanthenes | |
tranylcypromine | [no description available] | medium | 1 | 0 | 2-phenylcyclopropan-1-amine | |
dronedarone | [no description available] | medium | 1 | 0 | 1-benzofurans; aromatic ether; aromatic ketone; sulfonamide; tertiary amino compound | anti-arrhythmia drug; environmental contaminant; xenobiotic |
oleic acid | [no description available] | medium | 1 | 0 | octadec-9-enoic acid | antioxidant; Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; Escherichia coli metabolite; mouse metabolite; plant metabolite; solvent |
quercetin | [no description available] | medium | 1 | 0 | 7-hydroxyflavonol; pentahydroxyflavone | antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger |
fluorouracil | [no description available] | medium | 1 | 0 | nucleobase analogue; organofluorine compound | antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic |
fluoxetine | [no description available] | medium | 1 | 0 | (trifluoromethyl)benzenes; aromatic ether; secondary amino compound | |
halothane | [no description available] | medium | 1 | 0 | haloalkane; organobromine compound; organochlorine compound; organofluorine compound | inhalation anaesthetic |
phenacetin | [no description available] | medium | 8 | 0 | acetamides; aromatic ether | cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug |
riluzole | [no description available] | medium | 1 | 0 | benzothiazoles | |
sevoflurane | [no description available] | medium | 1 | 0 | ether; organofluorine compound | central nervous system depressant; inhalation anaesthetic; platelet aggregation inhibitor |
fluoroacetic acid | [no description available] | medium | 1 | 0 | haloacetic acid; organofluorine compound | EC 4.2.1.3 (aconitate hydratase) inhibitor |
alanine | [no description available] | medium | 2 | 0 | alanine zwitterion; alanine; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid | EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor; fundamental metabolite |
trifluoroethanol | [no description available] | medium | 1 | 0 | fluoroalcohol | |
1-chloro-2-nitrobenzene | [no description available] | medium | 1 | 0 | C-nitro compound; monochlorobenzenes | |
phenetole | [no description available] | medium | 1 | 0 | aromatic ether | |
2-chloropyridine | [no description available] | medium | 1 | 0 | monochloropyridine | |
tetrafluoroethylene | [no description available] | medium | 1 | 0 | fluorocarbon | |
hexafluoropropene | [no description available] | medium | 1 | 0 | | |
2-bromopropionic acid, (dl)-isomer | [no description available] | medium | 1 | 0 | | |
2-chloropropionic acid | [no description available] | medium | 1 | 0 | | |
alpha-fluoro-beta-alanine | [no description available] | medium | 1 | 0 | organonitrogen compound; organooxygen compound | |
perfluoroisobutylene | [no description available] | medium | 1 | 0 | | |
voriconazole | [no description available] | medium | 1 | 0 | conazole antifungal drug; difluorobenzene; pyrimidines; tertiary alcohol; triazole antifungal drug | P450 inhibitor |
neplanocin a | [no description available] | medium | 1 | 0 | | |
fludioxonil | [no description available] | medium | 1 | 0 | benzodioxoles; nitrile; organofluorine compound; pyrroles | androgen antagonist; antifungal agrochemical; estrogen receptor agonist |
2,6-diamino-9-(2-hydroxyethoxymethyl)purine | [no description available] | medium | 1 | 0 | | |
pa 824 | [no description available] | medium | 1 | 0 | | |
3,3,3-trifluoroalanine | [no description available] | medium | 1 | 0 | | |
benzyloxycarbonyl-phe-ala-fluormethylketone | [no description available] | medium | 1 | 0 | | |
fluticasone furoate | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 2-furoate ester; 3-oxo-Delta(1),Delta(4)-steroid; corticosteroid; fluorinated steroid; steroid ester; thioester | anti-allergic agent; anti-asthmatic drug; prodrug |
10,10-bis((2-fluoro-4-pyridinyl)methyl)-9(10h)-anthracenone | [no description available] | medium | 1 | 0 | anthracenes | |
anacetrapib | [no description available] | medium | 1 | 0 | | |
lumacaftor | [no description available] | medium | 1 | 0 | aromatic amide; benzodioxoles; benzoic acids; cyclopropanes; organofluorine compound; pyridines | CFTR potentiator; orphan drug |
everolimus | [no description available] | medium | 1 | 0 | cyclic acetal; cyclic ketone; ether; macrolide lactam; primary alcohol; secondary alcohol | anticoronaviral agent; antineoplastic agent; geroprotector; immunosuppressive agent; mTOR inhibitor |
azd2014 | [no description available] | medium | 1 | 0 | | |
diphenyl | [no description available] | medium | 2 | 0 | aromatic fungicide; benzenes; biphenyls | antifungal agrochemical; antimicrobial food preservative |
n-methylpyrrolidone | [no description available] | medium | 1 | 0 | lactam; N-alkylpyrrolidine; pyrrolidin-2-ones | polar aprotic solvent |
propofol | [no description available] | medium | 2 | 0 | phenols | anticonvulsant; antiemetic; intravenous anaesthetic; radical scavenger; sedative |
pentoxyresorufin | [no description available] | medium | 7 | 0 | | |
rifampin | [no description available] | medium | 1 | 0 | cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion | angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor |
azinphosmethyl | [no description available] | medium | 1 | 0 | benzotriazines; organic thiophosphate; organothiophosphate insecticide | agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor |
prizes | [no description available] | medium | 1 | 0 | carboxamidine; monochloropyridine; nitrile | environmental contaminant; neonicotinoid insectide; xenobiotic |
thiacloprid | [no description available] | medium | 1 | 0 | monochloropyridine; nitrile; thiazolidines | environmental contaminant; neonicotinoid insectide; xenobiotic |
7-methylcoumarin | [no description available] | medium | 1 | 0 | coumarins | |
genistein | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor |
urea | [no description available] | medium | 9 | 0 | isourea; monocarboxylic acid amide; one-carbon compound | Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
nicotine | [no description available] | medium | 1 | 0 | 3-(1-methylpyrrolidin-2-yl)pyridine | anxiolytic drug; biomarker; immunomodulator; mitogen; neurotoxin; nicotinic acetylcholine receptor agonist; peripheral nervous system drug; phytogenic insecticide; plant metabolite; psychotropic drug; teratogenic agent; xenobiotic |
prochloraz | [no description available] | medium | 2 | 0 | amide fungicide; aromatic ether; conazole fungicide; imidazole fungicide; imidazoles; trichlorobenzene; ureas | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; environmental contaminant; xenobiotic |
titanium | [no description available] | medium | 1 | 0 | titanium group element atom | |
titanium dioxide | [no description available] | medium | 1 | 0 | titanium oxides | food colouring |
buspirone | [no description available] | medium | 1 | 0 | azaspiro compound; N-alkylpiperazine; N-arylpiperazine; organic heteropolycyclic compound; piperidones; pyrimidines | anxiolytic drug; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; sedative; serotonergic agonist |
promazine | [no description available] | medium | 1 | 0 | phenothiazines; tertiary amine | antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; H1-receptor antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; serotonergic antagonist |
pyrethrins | [no description available] | medium | 1 | 0 | | |
propiconazole | [no description available] | medium | 1 | 0 | conazole fungicide; cyclic ketal; dichlorobenzene; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; environmental contaminant; xenobiotic |
triazoles | [no description available] | medium | 3 | 0 | 1,2,3-triazole | |
caffeine | [no description available] | medium | 4 | 0 | purine alkaloid; trimethylxanthine | adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic |
resorcinol | [no description available] | medium | 1 | 0 | benzenediol; phenolic donor; resorcinols | erythropoietin inhibitor; sensitiser |
deoxyguanosine | [no description available] | medium | 1 | 0 | purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
pentachlorophenol | [no description available] | medium | 1 | 0 | aromatic fungicide; chlorophenol; organochlorine pesticide; pentachlorobenzenes | human xenobiotic metabolite |
8-hydroxy-2'-deoxyguanosine | [no description available] | medium | 1 | 0 | guanosines | biomarker |
beta-naphthoflavone | [no description available] | medium | 19 | 0 | extended flavonoid; naphtho-gamma-pyrone; organic heterotricyclic compound | aryl hydrocarbon receptor agonist |
pregnenolone carbonitrile | [no description available] | medium | 2 | 0 | aliphatic nitrile | |
phenobarbital | [no description available] | medium | 23 | 0 | barbiturates | anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative |
dimethyl sulfoxide | [no description available] | medium | 2 | 0 | sulfoxide; volatile organic compound | alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger |
benzo(a)pyrene | [no description available] | medium | 17 | 0 | ortho- and peri-fused polycyclic arene | carcinogenic agent; mouse metabolite |
resorufin | [no description available] | medium | 2 | 0 | phenoxazine | |
ethoxyresorufin | [no description available] | medium | 25 | 0 | phenoxazine | |
hesperidin | [no description available] | medium | 1 | 0 | 3'-hydroxyflavanones; 4'-methoxyflavanones; dihydroxyflavanone; disaccharide derivative; flavanone glycoside; monomethoxyflavanone; rutinoside | mutagen |
hesperetin | [no description available] | medium | 1 | 0 | 3'-hydroxyflavanones; 4'-methoxyflavanones; monomethoxyflavanone; trihydroxyflavanone | antineoplastic agent; antioxidant; plant metabolite |
indigo carmine | [no description available] | medium | 1 | 0 | | |
heme | [no description available] | medium | 3 | 0 | | |
indole | [no description available] | medium | 1 | 0 | indole; polycyclic heteroarene | Escherichia coli metabolite |
4-nitrophenol | [no description available] | medium | 11 | 0 | 4-nitrophenols | human xenobiotic metabolite; mouse metabolite |
nitrophenols | [no description available] | medium | 12 | 0 | | |
metyrapone | [no description available] | medium | 6 | 0 | aromatic ketone | antimetabolite; diagnostic agent; EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor |
tafluprost | [no description available] | medium | 1 | 0 | isopropyl ester; organofluorine compound; prostaglandins Falpha | prostaglandin receptor agonist |
deuterium | [no description available] | medium | 5 | 0 | dihydrogen | |
7-ethoxy-4-trifluoromethylcoumarin | [no description available] | medium | 2 | 0 | | |
safrole | [no description available] | medium | 1 | 0 | benzodioxoles | flavouring agent; insecticide; metabolite; plant metabolite |
pinocembrin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; dihydroxyflavanone | antineoplastic agent; antioxidant; metabolite; neuroprotective agent; vasodilator agent |
resazurin | [no description available] | medium | 1 | 0 | phenoxazine | |
dextromethorphan | [no description available] | medium | 1 | 0 | 6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene | antitussive; environmental contaminant; neurotoxin; NMDA receptor antagonist; oneirogen; prodrug; xenobiotic |
diphenhydramine hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride; organoammonium salt | anti-allergic agent; antiemetic; antiparkinson drug; antipruritic drug; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; sedative |
xanthenes | [no description available] | medium | 1 | 0 | xanthene | |
methylphenyl carbinol | [no description available] | medium | 1 | 0 | aromatic alcohol | mouse metabolite |
mtt formazan | [no description available] | medium | 1 | 0 | | |
formazans | [no description available] | medium | 1 | 0 | | |
dinitrochlorobenzene | [no description available] | medium | 5 | 0 | C-nitro compound; monochlorobenzenes | allergen; epitope; sensitiser |
vilazodone hydrochloride | [no description available] | medium | 1 | 0 | hydrochloride | antidepressant; serotonergic agonist; serotonin uptake inhibitor |
benzofurans | [no description available] | medium | 1 | 0 | | |
lidocaine | [no description available] | medium | 5 | 0 | benzenes; monocarboxylic acid amide; tertiary amino compound | anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic |
tretinoin | [no description available] | medium | 3 | 0 | retinoic acid; vitamin A | anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule |
catechin | [no description available] | medium | 1 | 0 | catechin | antioxidant; plant metabolite |
farnesol | [no description available] | medium | 1 | 0 | farnesol | plant metabolite |
naproxen | [no description available] | medium | 1 | 0 | methoxynaphthalene; monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; gout suppressant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
tolbutamide | [no description available] | medium | 4 | 0 | N-sulfonylurea | human metabolite; hypoglycemic agent; insulin secretagogue; potassium channel blocker |
methoxychlor | [no description available] | medium | 1 | 0 | organochlorine insecticide | |
ketoconazole | [no description available] | medium | 2 | 0 | dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine | |
midazolam | [no description available] | medium | 1 | 0 | imidazobenzodiazepine; monofluorobenzenes; organochlorine compound | anticonvulsant; antineoplastic agent; anxiolytic drug; apoptosis inducer; central nervous system depressant; GABAA receptor agonist; general anaesthetic; muscle relaxant; sedative |
xanthohumol | [no description available] | medium | 1 | 0 | aromatic ether; chalcones; polyphenol | anti-HIV-1 agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.3.1.20 (diacylglycerol O-acyltransferase) inhibitor; metabolite |
flavanone | [no description available] | medium | 1 | 0 | flavanones | |
2-anthramine | [no description available] | medium | 1 | 0 | anthracenamine | |
4-nitroanisole | [no description available] | medium | 7 | 0 | 4-nitroanisoles | |
aniline | [no description available] | medium | 10 | 0 | anilines; primary arylamine | |
chlorodiphenyl (54% chlorine) | [no description available] | medium | 2 | 0 | | |
3-methylcholanthrene | [no description available] | medium | 11 | 0 | ortho- and peri-fused polycyclic arene | aryl hydrocarbon receptor agonist; carcinogenic agent |
ranitidine | [no description available] | medium | 1 | 0 | C-nitro compound; furans; organic sulfide; tertiary amino compound | anti-ulcer drug; drug allergen; environmental contaminant; H2-receptor antagonist; xenobiotic |
cimetidine | [no description available] | medium | 1 | 0 | aliphatic sulfide; guanidines; imidazoles; nitrile | adjuvant; analgesic; anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
1,3-diphenylpropane | [no description available] | medium | 1 | 0 | aromatic compound | |
propane | [no description available] | medium | 1 | 0 | alkane; gas molecular entity | food propellant |
chloroform | [no description available] | medium | 1 | 0 | chloromethanes; one-carbon compound | carcinogenic agent; central nervous system drug; inhalation anaesthetic; non-polar solvent; refrigerant |
phentermine | [no description available] | medium | 1 | 0 | primary amine | adrenergic agent; appetite depressant; central nervous system drug; central nervous system stimulant; dopaminergic agent; sympathomimetic agent |
proadifen | [no description available] | medium | 9 | 0 | diarylmethane | |
nad | [no description available] | medium | 3 | 0 | organophosphate oxoanion | cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite |
nadp | [no description available] | medium | 15 | 0 | | |
3,4,5,3',4',5'-hexachlorobiphenyl | [no description available] | medium | 1 | 0 | hexachlorobiphenyl; trichlorobenzene | |
aminopyrine | [no description available] | medium | 10 | 0 | pyrazolone; tertiary amino compound | antipyretic; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
potassium cyanide | [no description available] | medium | 2 | 0 | cyanide salt; one-carbon compound; potassium salt | EC 1.15.1.1 (superoxide dismutase) inhibitor; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; neurotoxin |
lysine | [no description available] | medium | 3 | 0 | aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid | algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
1-naphthol | [no description available] | medium | 1 | 0 | naphthol | genotoxin; human xenobiotic metabolite |
2-naphthol | [no description available] | medium | 1 | 0 | naphthol | antinematodal drug; genotoxin; human urinary metabolite; human xenobiotic metabolite; mouse metabolite; radical scavenger |
2,5-diphenyloxazole | [no description available] | medium | 2 | 0 | | |
oxazoles | [no description available] | medium | 2 | 0 | 1,3-oxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene | |
benzo(a)pyrene 4,5-epoxide | [no description available] | medium | 1 | 0 | carbopolycyclic compound | |
2-iodosobenzoic acid | [no description available] | medium | 1 | 0 | benzoic acids; organoiodine compound | EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor |
cumene hydroperoxide | [no description available] | medium | 8 | 0 | peroxol | environmental contaminant; Mycoplasma genitalium metabolite; oxidising agent |
chloramphenicol | [no description available] | medium | 1 | 0 | C-nitro compound; carboxamide; diol; organochlorine compound | antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor |
xylitol | [no description available] | medium | 1 | 0 | | |
sorbitol | [no description available] | medium | 1 | 0 | glucitol | cathartic; Escherichia coli metabolite; food humectant; human metabolite; laxative; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite; sweetening agent |
clobetasol | [no description available] | medium | 1 | 0 | 11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 3-oxo-Delta(1),Delta(4)-steroid; chlorinated steroid; fluorinated steroid; glucocorticoid; tertiary alpha-hydroxy ketone | anti-inflammatory drug; SMO receptor agonist |
aldrin | [no description available] | medium | 6 | 0 | | |
hydrazine | [no description available] | medium | 2 | 0 | azane; hydrazines | EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor |
paraquat | [no description available] | medium | 1 | 0 | organic cation | geroprotector; herbicide |
hexachlorobutadiene | [no description available] | medium | 1 | 0 | organochlorine compound | |
ampyrone | [no description available] | medium | 1 | 0 | primary amino compound; pyrazolone | antipyretic; antirheumatic drug; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; marine xenobiotic metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug |
1,3-cyclohexadiene | [no description available] | medium | 1 | 0 | cyclohexadiene | |
rotenone | [no description available] | medium | 1 | 0 | organic heteropentacyclic compound; rotenones | antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin |
cobalt | [no description available] | medium | 1 | 0 | cobalt group element atom; metal allergen | micronutrient |
1,3-dimethyluric acid | [no description available] | medium | 1 | 0 | oxopurine | metabolite |
uric acid | [no description available] | medium | 1 | 0 | uric acid | Escherichia coli metabolite; human metabolite; mouse metabolite |
enoxacin | [no description available] | medium | 1 | 0 | 1,8-naphthyridine derivative; amino acid; fluoroquinolone antibiotic; monocarboxylic acid; N-arylpiperazine; quinolone antibiotic | antibacterial drug; DNA synthesis inhibitor |
1-methylxanthine | [no description available] | medium | 1 | 0 | 1-methylxanthine | mouse metabolite |
phencyclidine | [no description available] | medium | 1 | 0 | benzenes; piperidines | anaesthetic; neurotoxin; NMDA receptor antagonist; psychotropic drug |
ipriflavone | [no description available] | medium | 1 | 0 | aromatic ether; isoflavones | bone density conservation agent |
imidocarb | [no description available] | medium | 1 | 0 | ureas | antiprotozoal drug |
7-hydroxycoumarin glucuronide | [no description available] | medium | 2 | 0 | beta-D-glucosiduronic acid | |
ovalbumin | [no description available] | medium | 1 | 0 | | |
benzphetamine | [no description available] | medium | 5 | 0 | amphetamines; tertiary amine | adrenergic uptake inhibitor; appetite depressant; dopamine uptake inhibitor; sympathomimetic agent |
glucuronic acid | [no description available] | medium | 2 | 0 | D-glucuronic acid | algal metabolite |
galactosamine | [no description available] | medium | 1 | 0 | D-galactosamine; primary amino compound | toxin |
carbon tetrachloride | [no description available] | medium | 2 | 0 | chlorocarbon; chloromethanes | hepatotoxic agent; refrigerant |
acetaminophen | [no description available] | medium | 2 | 0 | acetamides; phenols | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; cyclooxygenase 3 inhibitor; environmental contaminant; ferroptosis inducer; geroprotector; hepatotoxic agent; human blood serum metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
troleandomycin | [no description available] | medium | 1 | 0 | acetate ester; epoxide; macrolide antibiotic; monosaccharide derivative; polyketide; semisynthetic derivative | EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor; xenobiotic |
ifosfamide | [no description available] | medium | 1 | 0 | ifosfamides | alkylating agent; antineoplastic agent; environmental contaminant; immunosuppressive agent; xenobiotic |
naringenin | [no description available] | medium | 1 | 0 | (2S)-flavan-4-one; naringenin | expectorant; plant metabolite |
diethyl maleate | [no description available] | medium | 1 | 0 | ethyl ester; maleate ester | glutathione depleting agent |
mitomycin | [no description available] | medium | 1 | 0 | mitomycin | alkylating agent; antineoplastic agent |
7-hydroxy-4-trifluoromethylcoumarin | [no description available] | medium | 1 | 0 | | |
1,2-dilauroylphosphatidylcholine | [no description available] | medium | 1 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine(1+) | |
phosphatidylcholines | [no description available] | medium | 1 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine | |
1,2-distearoyllecithin | [no description available] | medium | 1 | 0 | | |
androstenedione | [no description available] | medium | 4 | 0 | 17-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite |
ethyldimethylaminopropyl carbodiimide | [no description available] | medium | 1 | 0 | | |
ammonium hydroxide | [no description available] | medium | 2 | 0 | azane; gas molecular entity; mononuclear parent hydride | EC 3.5.1.4 (amidase) inhibitor; metabolite; mouse metabolite; neurotoxin; NMR chemical shift reference compound; nucleophilic reagent; refrigerant |
lactic acid | [no description available] | medium | 1 | 0 | 2-hydroxy monocarboxylic acid | algal metabolite; Daphnia magna metabolite |
bilirubin | [no description available] | medium | 1 | 0 | biladienes; dicarboxylic acid | antioxidant; human metabolite; mouse metabolite |
edetic acid | [no description available] | medium | 1 | 0 | ethylenediamine derivative; polyamino carboxylic acid; tetracarboxylic acid | anticoagulant; antidote; chelator; copper chelator; geroprotector |
dimethylnitrosamine | [no description available] | medium | 2 | 0 | nitrosamine | geroprotector; mutagen |
fadrozole | [no description available] | medium | 1 | 0 | imidazopyridine | |
androst-4-ene-3,6,17-trione | [no description available] | medium | 1 | 0 | | |
agaritine | [no description available] | medium | 1 | 0 | amino acid zwitterion; benzyl alcohols; carbohydrazide; L-glutamic acid derivative; non-proteinogenic L-alpha-amino acid | |
allyl formate | [no description available] | medium | 1 | 0 | | |
allyl alcohol | [no description available] | medium | 2 | 0 | primary allylic alcohol; propenol | antibacterial agent; fungicide; herbicide; insecticide; plant metabolite |
1-propanol | [no description available] | medium | 3 | 0 | propan-1-ols; short-chain primary fatty alcohol | metabolite; protic solvent |
potassium phosphate | [no description available] | medium | 1 | 0 | inorganic phosphate salt; inorganic potassium salt | |
glucose, (beta-d)-isomer | [no description available] | medium | 1 | 0 | D-glucopyranose | epitope; mouse metabolite |
chlormezanone | [no description available] | medium | 1 | 0 | 1,3-thiazine; lactam; monochlorobenzenes; sulfone | antipsychotic agent; anxiolytic drug; muscle relaxant |
ethylmorphine | [no description available] | medium | 4 | 0 | morphinane alkaloid | |
mequitazine | [no description available] | medium | 1 | 0 | phenothiazines | |
cyclosporine | [no description available] | medium | 1 | 0 | | |
4-nitrosodimethylaniline | [no description available] | medium | 1 | 0 | dimethylaniline; nitroso compound; tertiary amino compound | |
phenyl-n-tert-butylnitrone | [no description available] | medium | 1 | 0 | | |
buthionine sulfoximine | [no description available] | medium | 1 | 0 | diastereoisomeric mixture; homocysteines; non-proteinogenic alpha-amino acid; sulfoximide | EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor; ferroptosis inducer |
fomepizole | [no description available] | medium | 2 | 0 | pyrazoles | antidote; EC 1.1.1.1 (alcohol dehydrogenase) inhibitor; protective agent |
isoniazid | [no description available] | medium | 1 | 0 | carbohydrazide | antitubercular agent; drug allergen |
1-aminobenzotriazole | [no description available] | medium | 1 | 0 | | |
potassium chloride | [no description available] | medium | 1 | 0 | inorganic chloride; inorganic potassium salt; potassium salt | fertilizer |
bufuralol | [no description available] | medium | 1 | 0 | benzofurans | |
nifedipine | [no description available] | medium | 1 | 0 | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
cholecalciferol | [no description available] | medium | 1 | 0 | D3 vitamins; hydroxy seco-steroid; seco-cholestane; secondary alcohol; steroid hormone | geroprotector; human metabolite |
lauric acid | [no description available] | medium | 1 | 0 | medium-chain fatty acid; straight-chain saturated fatty acid | algal metabolite; antibacterial agent; plant metabolite |
arachidonic acid | [no description available] | medium | 1 | 0 | icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid | Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite |
salmeterol xinafoate | [no description available] | medium | 1 | 0 | naphthoic acid | |
albuterol | [no description available] | medium | 1 | 0 | phenols; phenylethanolamines; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; environmental contaminant; xenobiotic |
clenbuterol | [no description available] | medium | 1 | 0 | amino alcohol; dichlorobenzene; ethanolamines; primary arylamine; secondary amino compound; substituted aniline | beta-adrenergic agonist; bronchodilator agent; sympathomimetic agent |
hexacyanoferrate iii | [no description available] | medium | 1 | 0 | | |
chlortoluron | [no description available] | medium | 1 | 0 | monochlorobenzenes; phenylureas | agrochemical; environmental contaminant; herbicide; xenobiotic |
vitamin k semiquinone radical | [no description available] | medium | 1 | 0 | | |
retinol | [no description available] | medium | 1 | 0 | retinol; vitamin A | human metabolite; mouse metabolite; plant metabolite |
retinol palmitate | [no description available] | medium | 1 | 0 | all-trans-retinyl ester; retinyl palmitate | antioxidant; Escherichia coli metabolite; human xenobiotic metabolite |
sodium azide | [no description available] | medium | 1 | 0 | inorganic sodium salt | antibacterial agent; explosive; mitochondrial respiratory-chain inhibitor; mutagen |
beta carotene | [no description available] | medium | 1 | 0 | carotenoid beta-end derivative; cyclic carotene | antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A |
singlet oxygen | [no description available] | medium | 1 | 0 | chalcogen; monoatomic oxygen; nonmetal atom | macronutrient |
triacetoneamine-n-oxyl | [no description available] | medium | 1 | 0 | aminoxyls; piperidones | radical scavenger |
tempidon | [no description available] | medium | 1 | 0 | piperidones | |
2-piperidone | [no description available] | medium | 1 | 0 | delta-lactam; piperidones | EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor |
hexobarbital | [no description available] | medium | 1 | 0 | barbiturates | |
isoproterenol | [no description available] | medium | 1 | 0 | catechols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent |
morphine | [no description available] | medium | 1 | 0 | morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound | anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic |
alamethicin | [no description available] | medium | 2 | 0 | | |
sodium iodide | [no description available] | medium | 1 | 0 | inorganic sodium salt; iodide salt | |
xylose | [no description available] | medium | 1 | 0 | D-xylose | |
cholic acid | [no description available] | medium | 1 | 0 | 12alpha-hydroxy steroid; 3alpha-hydroxy steroid; 7alpha-hydroxy steroid; bile acid; C24-steroid; trihydroxy-5beta-cholanic acid | human metabolite; mouse metabolite |
methanol | [no description available] | medium | 1 | 0 | alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound | amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite |
glycerol | [no description available] | medium | 1 | 0 | alditol; triol | algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent |
6-hydroxychlorzoxazone | [no description available] | medium | 1 | 0 | benzoxazole | |
emd 53998 | [no description available] | medium | 1 | 0 | | |
phenolsulfonphthalein | [no description available] | medium | 1 | 0 | 2,1-benzoxathiole; arenesulfonate ester; phenols; sultone | acid-base indicator; diagnostic agent; two-colour indicator |
dicumarol | [no description available] | medium | 1 | 0 | hydroxycoumarin | anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; Hsp90 inhibitor; vitamin K antagonist |
flavin-adenine dinucleotide | [no description available] | medium | 2 | 0 | flavin adenine dinucleotide; vitamin B2 | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; prosthetic group |
nitrites | [no description available] | medium | 2 | 0 | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | human metabolite |
isosorbide dinitrate | [no description available] | medium | 1 | 0 | glucitol derivative; nitrate ester | nitric oxide donor; vasodilator agent |
nitroglycerin | [no description available] | medium | 1 | 0 | nitroglycerol | explosive; muscle relaxant; nitric oxide donor; prodrug; tocolytic agent; vasodilator agent; xenobiotic |
noc 7 | [no description available] | medium | 1 | 0 | | |
nitrates | [no description available] | medium | 1 | 0 | monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species | |
uridine diphosphate glucuronic acid | [no description available] | medium | 1 | 0 | UDP-D-glucuronic acid | Escherichia coli metabolite; human metabolite; mouse metabolite |
lysophosphatidylcholines | [no description available] | medium | 1 | 0 | 1-O-acyl-sn-glycero-3-phosphocholine | |
glutamic acid | [no description available] | medium | 1 | 0 | glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical |
flavin mononucleotide | [no description available] | medium | 1 | 0 | | |
glycogen | [no description available] | medium | 1 | 0 | | |
acetic anhydride | [no description available] | medium | 1 | 0 | acyclic carboxylic anhydride | metabolite; reagent |
indocyanine green | [no description available] | medium | 1 | 0 | 1,1-diunsubstituted alkanesulfonate; benzoindole; cyanine dye | |
dipyrone | [no description available] | medium | 1 | 0 | organic sodium salt | anti-inflammatory agent; antipyretic; antirheumatic drug; cyclooxygenase 3 inhibitor; non-narcotic analgesic; peripheral nervous system drug; prodrug |
2-dichlorobenzene | [no description available] | medium | 2 | 0 | dichlorobenzene | hepatotoxic agent; metabolite |
4-dichlorobenzene | [no description available] | medium | 2 | 0 | dichlorobenzene | insecticide |
1,3-dichlorobenzene | [no description available] | medium | 2 | 0 | dichlorobenzene | |
tetcyclacis | [no description available] | medium | 1 | 0 | | |
lithocholic acid | [no description available] | medium | 1 | 0 | bile acid; C24-steroid; monohydroxy-5beta-cholanic acid | geroprotector; human metabolite; mouse metabolite |
estrone | [no description available] | medium | 2 | 0 | 17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols | antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite |
styrene oxide | [no description available] | medium | 1 | 0 | epoxide | human xenobiotic metabolite |
sulfamethazine | [no description available] | medium | 1 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic |
furazolidone | [no description available] | medium | 1 | 0 | nitrofuran antibiotic; oxazolidines | antibacterial drug; antiinfective agent; antitrichomonal drug; EC 1.4.3.4 (monoamine oxidase) inhibitor |
cyanides | [no description available] | medium | 1 | 0 | pseudohalide anion | EC 1.9.3.1 (cytochrome c oxidase) inhibitor |
amitrole | [no description available] | medium | 1 | 0 | aromatic amine; triazoles | carotenoid biosynthesis inhibitor; EC 1.11.1.6 (catalase) inhibitor; herbicide |
pyrazines | [no description available] | medium | 1 | 0 | diazine; pyrazines | Daphnia magna metabolite |
ethinyl estradiol | [no description available] | medium | 1 | 0 | 17-hydroxy steroid; 3-hydroxy steroid; terminal acetylenic compound | xenoestrogen |
terbinafine | [no description available] | medium | 1 | 0 | acetylenic compound; allylamine antifungal drug; enyne; naphthalenes; tertiary amine | EC 1.14.13.132 (squalene monooxygenase) inhibitor; P450 inhibitor; sterol biosynthesis inhibitor |
methyl n-butyl ketone | [no description available] | medium | 1 | 0 | ketone | |
acetone | [no description available] | medium | 1 | 0 | ketone body; methyl ketone; propanones; volatile organic compound | EC 3.5.1.4 (amidase) inhibitor; human metabolite; polar aprotic solvent |
stanozolol | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; anabolic androgenic steroid; organic heteropentacyclic compound; tertiary alcohol | anabolic agent; androgen |
spermine | [no description available] | medium | 1 | 0 | polyazaalkane; tetramine | antioxidant; fundamental metabolite; immunosuppressive agent |
parathion | [no description available] | medium | 1 | 0 | C-nitro compound; organic thiophosphate; organothiophosphate insecticide | acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; mouse metabolite |
spermidine | [no description available] | medium | 1 | 0 | polyazaalkane; triamine | autophagy inducer; fundamental metabolite; geroprotector |
putrescine | [no description available] | medium | 1 | 0 | alkane-alpha,omega-diamine | antioxidant; fundamental metabolite |
benz(a)anthracene | [no description available] | medium | 2 | 0 | ortho-fused polycyclic arene; tetraphenes | |
nonoxynol | [no description available] | medium | 1 | 0 | | |
benzo(e)pyrene | [no description available] | medium | 1 | 0 | ortho- and peri-fused polycyclic arene | carcinogenic agent; mutagen |
methylamine | [no description available] | medium | 1 | 0 | methylamines; one-carbon compound; primary aliphatic amine | mouse metabolite |
ethyl acetimidate | [no description available] | medium | 1 | 0 | | |
butylated hydroxytoluene | [no description available] | medium | 1 | 0 | phenols | antioxidant; ferroptosis inhibitor; food additive; geroprotector |
diisopropyl 1,3-dithiol-2-ylidenemalonate | [no description available] | medium | 1 | 0 | isopropyl ester | |
ammonium sulfate | [no description available] | medium | 1 | 0 | ammonium salt; inorganic sulfate salt | fertilizer |
benzene | [no description available] | medium | 1 | 0 | aromatic annulene; benzenes; volatile organic compound | carcinogenic agent; environmental contaminant; non-polar solvent |
pyridine | [no description available] | medium | 1 | 0 | azaarene; mancude organic heteromonocyclic parent; monocyclic heteroarene; pyridines | environmental contaminant; NMR chemical shift reference compound |
precocene ii | [no description available] | medium | 1 | 0 | chromenes | precocenes |
toluene | [no description available] | medium | 1 | 0 | methylbenzene; toluenes; volatile organic compound | cholinergic antagonist; fuel additive; neurotoxin; non-polar solvent |
hempa | [no description available] | medium | 1 | 0 | phosphoramide | insect sterilant; mutagen |
chlormethiazole | [no description available] | medium | 1 | 0 | thiazoles | |
d-alpha tocopherol | [no description available] | medium | 1 | 0 | alpha-tocopherol | algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite |
carbon monoxide | [no description available] | medium | 2 | 0 | carbon oxide; gas molecular entity; one-carbon compound | biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent |
2,6-dihydroxyanthraquinone | [no description available] | medium | 1 | 0 | dihydroxyanthraquinone | antimutagen; plant metabolite |
2-butanol | [no description available] | medium | 1 | 0 | secondary alcohol | |
pyrazole | [no description available] | medium | 1 | 0 | pyrazole | |
sodium dodecyl sulfate | [no description available] | medium | 1 | 0 | organic sodium salt | detergent; protein denaturant |
1-butanol | [no description available] | medium | 1 | 0 | alkyl alcohol; primary alcohol; short-chain primary fatty alcohol | human metabolite; mouse metabolite; protic solvent |
cortisol 21-mesylate | [no description available] | medium | 1 | 0 | | |
n,n'-diphenyl-4-phenylenediamine | [no description available] | medium | 1 | 0 | N-substituted diamine; secondary amino compound | antioxidant |
carmustine | [no description available] | medium | 1 | 0 | N-nitrosoureas; organochlorine compound | alkylating agent; antineoplastic agent |
deferoxamine | [no description available] | medium | 1 | 0 | acyclic desferrioxamine | bacterial metabolite; ferroptosis inhibitor; iron chelator; siderophore |
hydroxyphenytoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione; phenols | metabolite |
nordazepam | [no description available] | medium | 1 | 0 | 1,4-benzodiazepinone; organochlorine compound | anticonvulsant; anxiolytic drug; GABA modulator; human metabolite; sedative |
phenytoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | anticonvulsant; drug allergen; sodium channel blocker; teratogenic agent |
cyclopropylbenzene | [no description available] | medium | 1 | 0 | | |
triiodothyronine | [no description available] | medium | 1 | 0 | 2-halophenol; amino acid zwitterion; iodophenol; iodothyronine | human metabolite; mouse metabolite; thyroid hormone |
5,7-dimethoxycoumarin | [no description available] | low | 0 | 0 | coumarins | |
6-methylcoumarin | [no description available] | low | 0 | 0 | coumarins | allergen; fragrance |
osthol | [no description available] | low | 0 | 0 | botanical anti-fungal agent; coumarins | metabolite |
cyclocumarol | [no description available] | low | 0 | 0 | coumarins | |
chromonar | [no description available] | low | 0 | 0 | coumarins | |
xanthyletine | [no description available] | low | 0 | 0 | coumarins | |
xanthoxyletin | [no description available] | low | 0 | 0 | coumarins | metabolite |
seselin | [no description available] | low | 0 | 0 | coumarins | metabolite |
suberosin | [no description available] | low | 0 | 0 | aromatic ether; coumarins | anticoagulant; plant metabolite |
cloricromen | [no description available] | low | 0 | 0 | coumarins | |
3-acetylcoumarin | [no description available] | low | 0 | 0 | coumarins | |
4-methylumbelliferyl sulfate | [no description available] | low | 0 | 0 | aryl sulfate; coumarins | human xenobiotic metabolite |
4-methylumbelliferyl butyrate | [no description available] | low | 0 | 0 | butyrate ester; coumarins | chromogenic compound |
7-(diethylamino)-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
4-methylumbelliferyl glucuronide | [no description available] | low | 0 | 0 | beta-D-glucosiduronic acid; coumarins; monosaccharide derivative | antineoplastic agent; chromogenic compound; hyaluronan synthesis inhibitor |
4-methylumbelliferyl-galactopyranoside | [no description available] | low | 0 | 0 | beta-D-galactoside; coumarins; monosaccharide derivative | chromogenic compound |
skimmin | [no description available] | low | 0 | 0 | coumarins; glycoside | |
n-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide | [no description available] | low | 0 | 0 | benzenes; coumarins; maleimides; tertiary amino compound | fluorescent dye |
4-methylumbelliferylcellobioside | [no description available] | low | 0 | 0 | coumarins; glycoside | |
N-(2-oxo-1-benzopyran-3-yl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
bucumolol | [no description available] | low | 0 | 0 | coumarins | |
3-chloro-7-methoxy-4-methyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
khellactone | [no description available] | low | 0 | 0 | coumarins | |
dentatin | [no description available] | low | 0 | 0 | coumarins | metabolite |
rosiglitazone | [no description available] | low | 0 | 0 | acetate ester; coumarins; diester | pro-angiogenic agent; radical scavenger |
5,7-dimethoxy-4-methyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
scopolin | [no description available] | low | 0 | 0 | beta-D-glucoside; coumarins; monosaccharide derivative | plant metabolite |
decursin | [no description available] | low | 0 | 0 | coumarins | |
visnadin | [no description available] | low | 0 | 0 | coumarins | |
glycyrin | [no description available] | low | 0 | 0 | aromatic ether; coumarins; hydroxyisoflavans | antibacterial agent; metabolite; plant metabolite |
6-methyl-4-(morpholinomethyl)-2H-chromen-2-one | [no description available] | low | 0 | 0 | coumarins | |
lomatin | [no description available] | low | 0 | 0 | coumarins | |
2-[(6-chloro-2-oxo-4-propyl-1-benzopyran-7-yl)oxy]-N,N-dimethylacetamide | [no description available] | low | 0 | 0 | coumarins | |
2-oxo-N-(2-pyridinylmethyl)-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
N-[3-(4-morpholinyl)propyl]-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
8-methoxy-N-(6-methyl-2-pyridinyl)-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
2-[(6-chloro-4-ethyl-2-oxo-1-benzopyran-7-yl)oxy]propanoic acid | [no description available] | low | 0 | 0 | coumarins | |
4,8-dimethyl-3-(phenylmethyl)-7-(2H-tetrazol-5-ylmethoxy)-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
1-[1-oxo-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]ethyl]-4-piperidinecarboxylic acid | [no description available] | low | 0 | 0 | coumarins | |
3-[4,8-dimethyl-2-oxo-7-(2H-tetrazol-5-ylmethoxy)-1-benzopyran-3-yl]propanoic acid ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
3,4,7-trimethyl-5-(3-oxobutan-2-yloxy)-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
4,9-dimethyl-3-(2H-tetrazol-5-ylmethoxy)-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-6-one | [no description available] | low | 0 | 0 | coumarins | |
4-[(4-ethyl-1-piperazinyl)methyl]-5,7-dimethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
7-[(3,5-dimethyl-4-isoxazolyl)methoxy]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
7-(diethylamino)-2-oxo-1-benzopyran-3-carbonitrile | [no description available] | low | 0 | 0 | coumarins | |
2-oxo-N-(3-pyridinylmethyl)-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
2-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-1-yl)oxy]acetic acid propan-2-yl ester | [no description available] | low | 0 | 0 | coumarins; isopropyl ester | |
5-methyl-4-[(2-oxo-1-benzopyran-7-yl)oxymethyl]-2-furancarboxylic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
6-methoxy-2-oxo-N-(3-pyridinylmethyl)-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
(4-Methyl-2-oxochromen-7-yl) furan-2-carboxylate | [no description available] | low | 0 | 0 | coumarins | anticoronaviral agent |
2-furancarboxylic acid (7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-9-yl) ester | [no description available] | low | 0 | 0 | coumarins | |
N-(4-amino-2-oxo-1-benzopyran-3-yl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
3-(8-methyl-2-imidazo[1,2-a]pyridinyl)-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
(4-Ethyl-2-oxochromen-7-yl) furan-2-carboxylate | [no description available] | low | 0 | 0 | coumarins | anticoronaviral agent |
5-(3,3-dimethyl-2-oxobutoxy)-4-ethyl-7-methyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
7-methoxy-4,8-dimethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
8-chloro-7-propan-2-yloxy-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-4-one | [no description available] | low | 0 | 0 | coumarins | |
2-[(3-ethyl-4-methyl-2-oxo-1-benzopyran-7-yl)oxy]acetic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
2-(2,3-dimethylphenoxy)-N-(2-oxo-1-benzopyran-6-yl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
1-(4-methyl-2-oxo-1-benzopyran-7-yl)-3-(2-pyridinylmethyl)thiourea | [no description available] | low | 0 | 0 | coumarins | |
8-methoxy-N-methyl-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
4-methyl-6-[2-(4-methyl-1-piperidinyl)-2-oxoethoxy]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
3-[(4-benzoyl-1-piperazinyl)-oxomethyl]-8-methoxy-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
3-[(4-nitrophenyl)methoxy]-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-6-one | [no description available] | low | 0 | 0 | coumarins | |
3-[2-(4-aminoanilino)-4-thiazolyl]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
2-[(4-methyl-2-oxo-1-benzopyran-7-yl)oxy]-N-(5-propan-2-yl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
3-[oxo-[4-(2-phenylethyl)-1-piperazinyl]methyl]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
6-bromo-N-[2-(dimethylamino)ethyl]-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
8-methoxy-6-nitro-3-[oxo-(2-phenyl-4,5-dihydroimidazol-1-yl)methyl]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
N-cyclohexyl-2-[(8-methoxy-6-oxo-3-benzo[c][1]benzopyranyl)oxy]acetamide | [no description available] | low | 0 | 0 | coumarins | |
5-methyl-4-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-1-yl)oxymethyl]-2-furancarboxylic acid | [no description available] | low | 0 | 0 | coumarins | |
5-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-1-yl)oxymethyl]-2-furancarboxylic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
4-methyl-3-(phenylmethyl)-7-[(3,4,5-trimethoxyphenyl)methoxy]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
5-(3,3-dimethyl-2-oxobutoxy)-3,4,7-trimethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
Methyl 7-methoxycoumarin-4-acetate | [no description available] | low | 0 | 0 | coumarins | |
2-[(7-methyl-4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-9-yl)oxy]acetic acid butyl ester | [no description available] | low | 0 | 0 | coumarins | |
4-(4-methylphenyl)-2-[[oxo-(2-oxo-1-benzopyran-3-yl)methyl]amino]-3-thiophenecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
5-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxymethyl]-2-furancarboxylic acid | [no description available] | low | 0 | 0 | coumarins | |
6-methyl-7-[2-nitro-4-(trifluoromethyl)phenoxy]-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-4-one | [no description available] | low | 0 | 0 | coumarins | |
3-methoxy-N-[[(2-oxo-1-benzopyran-6-yl)amino]-sulfanylidenemethyl]benzamide | [no description available] | low | 0 | 0 | coumarins | |
3-acetyl-7-methoxycoumarin | [no description available] | low | 0 | 0 | coumarins | |
acetic acid 2-[[oxo-(2-oxo-1-benzopyran-3-yl)methyl]amino]ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
4-(2,3-dihydroindol-1-ylmethyl)-7-ethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
3-[4-[(4,6-dioxo-2-sulfanylidene-1,3-diazinan-5-ylidene)methyl]-3-(2-oxo-1-benzopyran-3-yl)-1-pyrazolyl]propanoic acid | [no description available] | low | 0 | 0 | coumarins | |
2-[(3-methyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-2-yl)oxy]acetic acid ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
1-[oxo-(2-oxo-1-benzopyran-3-yl)methyl]-4-piperidinecarboxylic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
2-[(3,4-dimethyl-2-oxo-1-benzopyran-7-yl)oxy]acetic acid prop-2-enyl ester | [no description available] | low | 0 | 0 | coumarins | |
2-[(3,4,8-trimethyl-2-oxo-1-benzopyran-7-yl)oxy]acetic acid prop-2-enyl ester | [no description available] | low | 0 | 0 | coumarins | |
1-(2-hydroxyethyl)-4-[1]benzopyrano[3,4-d]triazolone | [no description available] | low | 0 | 0 | coumarins | |
2-[(4-methyl-2-oxo-1-benzopyran-7-yl)oxy]-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
4-[(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)methyl]-7-ethyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
N-cyclohexyl-2-[(4-oxo-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-7-yl)oxy]acetamide | [no description available] | low | 0 | 0 | coumarins | |
3-bromo-N-(4-methyl-2-oxo-1-benzopyran-7-yl)benzamide | [no description available] | low | 0 | 0 | coumarins | |
3-[ethyl(phenyl)sulfamoyl]-4-methylbenzoic acid (4-methyl-2-oxo-1-benzopyran-7-yl) ester | [no description available] | low | 0 | 0 | coumarins | |
aflatoxin g2 | [no description available] | low | 0 | 0 | coumarins | |
4-methylumbelliferyl glucoside | [no description available] | low | 0 | 0 | beta-D-glucoside; coumarins; monosaccharide derivative | chromogenic compound |
6,8-difluoro-4-methylumbelliferyl phosphate | [no description available] | low | 0 | 0 | coumarins | |
2,3-dihydro-2,3-dihydroxyaflatoxin b(1) | [no description available] | low | 0 | 0 | coumarins | |
6,7,8-trimethoxycoumarin | [no description available] | low | 0 | 0 | coumarins | |
3-O-Acetylepisamarcandin | [no description available] | low | 0 | 0 | coumarins | |
conferone | [no description available] | low | 0 | 0 | coumarins | |
2-[(2-ethyl-6-oxo-7,8,9,10-tetrahydrobenzo[c][1]benzopyran-3-yl)oxy]acetic acid methyl ester | [no description available] | low | 0 | 0 | coumarins | |
N-[2-(1-cyclohexenyl)ethyl]-2-(4-oxo-1-[1]benzopyrano[4,3-c]pyrazolyl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
3-pyridinecarboxylic acid 2-[[oxo-(2-oxo-1-benzopyran-3-yl)methyl]amino]ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
N-(3-methoxypropyl)-2-(4-oxo-1-[1]benzopyrano[4,3-c]pyrazolyl)acetamide | [no description available] | low | 0 | 0 | coumarins | |
7-[[5-(4-methoxyphenyl)-4-thieno[2,3-d]pyrimidinyl]oxy]-4-methyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins; thienopyrimidine | |
N-(2-oxo-1-benzopyran-3-yl)cyclohexanecarboxamide | [no description available] | low | 0 | 0 | coumarins | |
4-[(4-chlorophenyl)methylamino]-3-nitro-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
2-(3-oxo-4H-1,4-benzothiazin-2-yl)acetic acid (7-methoxy-2-oxo-1-benzopyran-4-yl)methyl ester | [no description available] | low | 0 | 0 | coumarins | |
2-(3-oxo-4H-1,4-benzothiazin-2-yl)acetic acid (7-acetamido-2-oxo-1-benzopyran-4-yl)methyl ester | [no description available] | low | 0 | 0 | coumarins | |
Meranzin hydrate | [no description available] | low | 0 | 0 | coumarins | |
N-(1,1-dioxo-3-thiolanyl)-N-[(4-ethoxyphenyl)methyl]-2-oxo-1-benzopyran-3-carboxamide | [no description available] | low | 0 | 0 | coumarins | |
capillarisin | [no description available] | low | 0 | 0 | coumarins | |
pteryxin | [no description available] | low | 0 | 0 | coumarins | |
4-[1-[(4-methyl-2-oxo-1-benzopyran-7-yl)amino]-3-oxo-1H-isoindol-2-yl]-1-piperidinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | coumarins | |
glycycoumarin | [no description available] | low | 0 | 0 | aromatic ether; coumarins; resorcinols | antispasmodic drug; plant metabolite |
phebalosin | [no description available] | low | 0 | 0 | coumarins | |
urolithin b | [no description available] | low | 0 | 0 | coumarins | |
7-hydroxy-6-(4-morpholinylmethyl)-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-4-one | [no description available] | low | 0 | 0 | coumarins | |
3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one | [no description available] | low | 0 | 0 | coumarins | geroprotector |
N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]-8-methyl-4-oxo-2-thieno[3,2-c][1]benzopyrancarboxamide | [no description available] | low | 0 | 0 | coumarins | |
N-ethyl-8-methyl-4-oxo-N-(phenylmethyl)-2-thieno[3,2-c][1]benzopyrancarboxamide | [no description available] | low | 0 | 0 | coumarins | |
trichodermamide a | [no description available] | low | 0 | 0 | coumarins | |
3-hydroxy-3-methyl-5-oxo-5-[[3,4,5-trihydroxy-6-[[6-methoxy-2-oxo-3-[(2-oxo-1-benzopyran-7-yl)oxy]-1-benzopyran-7-yl]oxy]-2-oxanyl]methoxy]pentanoic acid | [no description available] | low | 0 | 0 | coumarins; glycoside | |
auraptenol | [no description available] | low | 0 | 0 | coumarins | |
foetidin | [no description available] | low | 0 | 0 | coumarins | |
ro5126766 | [no description available] | low | 0 | 0 | aryloxypyrimidine; coumarins; organofluorine compound; pyridines; sulfamides | antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
8-[1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)propyl]-5,7-dimethoxy-4-pentyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
5,7-dimethoxy-4-methyl-8-[3-(4-morpholinyl)-1-(3,4,5-trimethoxyphenyl)propyl]-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
8-{1-[4-(dimethylamino)phenyl]-3-(pyrrolidin-1-yl)propyl}-5,7-dimethoxy-4-pentyl-2H-chromen-2-one | [no description available] | low | 0 | 0 | aromatic ether; coumarins; pyrrolidines; tertiary amino compound | |
8-[3-(diethylamino)-1-(4-methoxyphenyl)propyl]-5,7-dimethoxy-4-pentyl-1-benzopyran-2-one | [no description available] | low | 0 | 0 | coumarins | |
coumermycin | [no description available] | low | 0 | 0 | aromatic amide; coumarins; glycoside; heteroarenecarboxylate ester; pyrroles | antimicrobial agent; antineoplastic agent; bacterial metabolite; DNA synthesis inhibitor; Hsp90 inhibitor; topoisomerase IV inhibitor |
urolithin c | [no description available] | low | 0 | 0 | coumarins | |
quinacrine | [no description available] | low | 0 | 0 | acridines; aromatic ether; organochlorine compound; tertiary amino compound | antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor |
vanilmandelic acid | [no description available] | low | 0 | 0 | 2-hydroxy monocarboxylic acid; aromatic ether; phenols | human metabolite |
4-(2,4-dichlorophenoxy)butyric acid | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; organochlorine compound | agrochemical; phenoxy herbicide; synthetic auxin |
win 52035 | [no description available] | low | 0 | 0 | aromatic ether | |
win 52084 | [no description available] | low | 0 | 0 | aromatic ether | |
5-(nonyloxy)tryptamine | [no description available] | low | 0 | 0 | aromatic ether; primary amino compound; tryptamines | serotonergic agonist |
methylbufotenin | [no description available] | low | 0 | 0 | aromatic ether; tertiary amino compound; tryptamine alkaloid | hallucinogen; plant metabolite |
5-methoxytryptamine | [no description available] | low | 0 | 0 | aromatic ether; primary amino compound; tryptamines | 5-hydroxytryptamine 2A receptor agonist; 5-hydroxytryptamine 2B receptor agonist; 5-hydroxytryptamine 2C receptor agonist; antioxidant; cardioprotective agent; human metabolite; mouse metabolite; neuroprotective agent; radiation protective agent; serotonergic agonist |
ro 48-8071 | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; bromobenzenes; monofluorobenzenes; olefinic compound; tertiary amino compound | antineoplastic agent; EC 5.4.99.7 (lanosterol synthase) inhibitor |
rtki cpd | [no description available] | low | 0 | 0 | aromatic ether; monochlorobenzenes; quinazolines | antineoplastic agent; antiviral agent; epidermal growth factor receptor antagonist; geroprotector |
amsacrine | [no description available] | low | 0 | 0 | acridines; aromatic ether; sulfonamide | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
aristolochic acid i | [no description available] | low | 0 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin |
2,4-dihydroxy-7-methoxy-1,4-benzoxazin-3-one | [no description available] | low | 0 | 0 | aromatic ether; benzoxazine; cyclic hydroxamic acid; lactol | allelochemical; plant metabolite |
bufetolol | [no description available] | low | 0 | 0 | aromatic ether | |
bufexamac | [no description available] | low | 0 | 0 | aromatic ether; hydroxamic acid | antipyretic; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
bunitrolol | [no description available] | low | 0 | 0 | aromatic ether | |
bupranolol | [no description available] | low | 0 | 0 | aromatic ether | |
cgp 12177 | [no description available] | low | 0 | 0 | aromatic ether; benzimidazoles; secondary alcohol; secondary amino compound | beta-adrenergic antagonist |
ciglitazone | [no description available] | low | 0 | 0 | aromatic ether; thiazolidinone | antineoplastic agent; insulin-sensitizing drug |
cirazoline | [no description available] | low | 0 | 0 | aromatic ether | |
clofibrate | [no description available] | low | 0 | 0 | aromatic ether; ethyl ester; monochlorobenzenes | anticholesteremic drug; antilipemic drug; geroprotector; PPARalpha agonist |
clofibric acid | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; monochlorobenzenes | anticholesteremic drug; antilipemic drug; antineoplastic agent; herbicide; marine xenobiotic metabolite; PPARalpha agonist |
colchicine, (+-)-isomer | [no description available] | low | 0 | 0 | acetamides; alkaloid; aromatic ether; carbotricyclic compound | microtubule-destabilising agent; plant metabolite |
croconazole | [no description available] | low | 0 | 0 | aromatic ether; conazole antifungal drug; imidazole antifungal drug; monochlorobenzenes | |
cypermethrin | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound | agrochemical; molluscicide; pyrethroid ester acaricide; pyrethroid ester insecticide |
racemethorphan | [no description available] | low | 0 | 0 | aromatic ether; morphinane alkaloid; morphinane-like compound; organic heterotetracyclic compound | |
dibucaine | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid amide; tertiary amino compound | topical anaesthetic |
dilacor xr | [no description available] | low | 0 | 0 | acetate ester; aromatic ether; benzothiazepine; lactam; tertiary amino compound | |
domiphen | [no description available] | low | 0 | 0 | aromatic ether | |
donepezil | [no description available] | low | 0 | 0 | aromatic ether; indanones; piperidines; racemate | EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; nootropic agent |
epirizole | [no description available] | low | 0 | 0 | aromatic ether | |
ethacrynic acid | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid | EC 2.5.1.18 (glutathione transferase) inhibitor; ion transport inhibitor; loop diuretic |
ethoxyquin | [no description available] | low | 0 | 0 | aromatic ether; quinolines | antifungal agrochemical; food antioxidant; genotoxin; geroprotector; herbicide; Hsp90 inhibitor; neuroprotective agent; UDP-glucuronosyltransferase activator |
ethoxzolamide | [no description available] | low | 0 | 0 | aromatic ether; benzothiazoles; sulfonamide | antiglaucoma drug; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
2-hexyloxybenzamide | [no description available] | low | 0 | 0 | aromatic ether; benzamides | antifungal agent |
carbonyl cyanide p-trifluoromethoxyphenylhydrazone | [no description available] | low | 0 | 0 | aromatic ether; hydrazone; nitrile; organofluorine compound | ATP synthase inhibitor; geroprotector; ionophore |
fenofibrate | [no description available] | low | 0 | 0 | aromatic ether; chlorobenzophenone; isopropyl ester; monochlorobenzenes | antilipemic drug; environmental contaminant; geroprotector; xenobiotic |
fenvalerate | [no description available] | low | 0 | 0 | aromatic ether; carboxylic ester; monochlorobenzenes | pyrethroid ester acaricide; pyrethroid ester insecticide |
flecainide | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid amide; organofluorine compound; piperidines | anti-arrhythmia drug |
gallamine triethiodide | [no description available] | low | 0 | 0 | aromatic ether | |
gemfibrozil | [no description available] | low | 0 | 0 | aromatic ether | antilipemic drug |
haloprogin | [no description available] | low | 0 | 0 | aromatic ether | |
ly 171883 | [no description available] | low | 0 | 0 | acetophenones; aromatic ether; phenols; tetrazoles | anti-asthmatic drug; leukotriene antagonist |
mephenesin | [no description available] | low | 0 | 0 | aromatic ether; glycerol ether | |
methocarbamol | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester; secondary alcohol | |
methoctramine | [no description available] | low | 0 | 0 | aromatic ether; tetramine | muscarinic antagonist |
methoxsalen | [no description available] | low | 0 | 0 | aromatic ether; psoralens | antineoplastic agent; cross-linking reagent; dermatologic drug; photosensitizing agent; plant metabolite |
metoprolol | [no description available] | low | 0 | 0 | aromatic ether; propanolamine; secondary alcohol; secondary amino compound | antihypertensive agent; beta-adrenergic antagonist; environmental contaminant; geroprotector; xenobiotic |
mexiletine | [no description available] | low | 0 | 0 | aromatic ether; primary amino compound | anti-arrhythmia drug |
midodrine | [no description available] | low | 0 | 0 | amino acid amide; aromatic ether; secondary alcohol | alpha-adrenergic agonist; prodrug; sympathomimetic agent; vasoconstrictor agent |
clorgyline | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; terminal acetylenic compound; tertiary amino compound | antidepressant; EC 1.4.3.4 (monoamine oxidase) inhibitor |
nefazodone | [no description available] | low | 0 | 0 | aromatic ether; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; triazoles | alpha-adrenergic antagonist; analgesic; antidepressant; serotonergic antagonist; serotonin uptake inhibitor |
nimesulide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
nisoxetine | [no description available] | low | 0 | 0 | aromatic ether; secondary amino compound | adrenergic uptake inhibitor; antidepressant |
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; sulfonamide | antineoplastic agent; cyclooxygenase 2 inhibitor |
oxprenolol | [no description available] | low | 0 | 0 | aromatic ether | |
pantoprazole | [no description available] | low | 0 | 0 | aromatic ether; benzimidazoles; organofluorine compound; pyridines; sulfoxide | anti-ulcer drug; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; environmental contaminant; xenobiotic |
pd 153035 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; bromobenzenes; quinazolines; secondary amino compound | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; epidermal growth factor receptor antagonist |
pentamidine | [no description available] | low | 0 | 0 | aromatic ether; carboxamidine; diether | anti-inflammatory agent; antifungal agent; calmodulin antagonist; chemokine receptor 5 antagonist; EC 2.3.1.48 (histone acetyltransferase) inhibitor; NMDA receptor antagonist; S100 calcium-binding protein B inhibitor; trypanocidal drug; xenobiotic |
pioglitazone | [no description available] | low | 0 | 0 | aromatic ether; pyridines; thiazolidinediones | antidepressant; cardioprotective agent; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor; ferroptosis inhibitor; geroprotector; hypoglycemic agent; insulin-sensitizing drug; PPARgamma agonist; xenobiotic |
piretanide | [no description available] | low | 0 | 0 | aromatic ether | |
pramoxine | [no description available] | low | 0 | 0 | aromatic ether; morpholines | local anaesthetic |
prazosin | [no description available] | low | 0 | 0 | aromatic ether; furans; monocarboxylic acid amide; piperazines; quinazolines | alpha-adrenergic antagonist; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor |
primaquine | [no description available] | low | 0 | 0 | aminoquinoline; aromatic ether; N-substituted diamine | antimalarial |
proglumetacin | [no description available] | low | 0 | 0 | aromatic ether; benzamides; carboxylic ester; monochlorobenzenes; N-acylindole; N-alkylpiperazine | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; lipoxygenase inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug |
propoxur | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester | acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor |
pyrilamine | [no description available] | low | 0 | 0 | aromatic ether; ethylenediamine derivative | H1-receptor antagonist |
sulfadimethoxine | [no description available] | low | 0 | 0 | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic |
tetrahydropapaverine | [no description available] | low | 0 | 0 | aromatic ether; benzylisoquinoline alkaloid; benzyltetrahydroisoquinoline; polyether; secondary amino compound | |
tilorone | [no description available] | low | 0 | 0 | aromatic ether; diether; fluoren-9-ones; tertiary amino compound | anti-inflammatory agent; antineoplastic agent; antiviral agent; interferon inducer; nicotinic acetylcholine receptor agonist |
ultram | [no description available] | low | 0 | 0 | aromatic ether; tertiary alcohol; tertiary amino compound | |
triclosan | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; monochlorobenzenes; phenols | antibacterial agent; antimalarial; drug allergen; EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; fungicide; persistent organic pollutant; xenobiotic |
viloxazine | [no description available] | low | 0 | 0 | aromatic ether | |
wb 4101 | [no description available] | low | 0 | 0 | aromatic ether; benzodioxine; secondary amino compound | alpha-adrenergic antagonist |
3,3',5-triiodothyropropionic acid | [no description available] | low | 0 | 0 | aromatic ether | |
methacetin | [no description available] | low | 0 | 0 | acetamides; aromatic ether | |
mestranol | [no description available] | low | 0 | 0 | 17beta-hydroxy steroid; aromatic ether; terminal acetylenic compound | prodrug; xenoestrogen |
visnagin | [no description available] | low | 0 | 0 | aromatic ether; furanochromone; polyketide | anti-inflammatory agent; antihypertensive agent; EC 1.1.1.37 (malate dehydrogenase) inhibitor; phytotoxin; plant metabolite; vasodilator agent |
2-tert-butyl-4-hydroxyanisole | [no description available] | low | 0 | 0 | aromatic ether; phenols | |
mecoprop | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; monochlorobenzenes | |
phenetidine | [no description available] | low | 0 | 0 | aromatic ether; substituted aniline | |
2-methyl-4-chlorophenoxy gamma-butyric acid | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; monochlorobenzenes | environmental contaminant; phenoxy herbicide; xenobiotic |
4-bromophenyl phenyl ether | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound | |
di-(4-aminophenyl)ether | [no description available] | low | 0 | 0 | aromatic ether | |
phenyl ether | [no description available] | low | 0 | 0 | aromatic ether | plant metabolite |
diglycidyl resorcinol ether | [no description available] | low | 0 | 0 | aromatic ether | |
dimethoxyphenylethylamine | [no description available] | low | 0 | 0 | alkaloid; aromatic ether; phenylethylamine | allergen; plant metabolite |
dichlorprop | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; monocarboxylic acid | |
3-tert-butyl-4-hydroxyanisole | [no description available] | low | 0 | 0 | aromatic ether; phenols | antioxidant; human xenobiotic metabolite |
ethyl vanillin | [no description available] | low | 0 | 0 | aromatic ether; benzaldehydes; phenols | antioxidant; flavouring agent |
benzethonium chloride | [no description available] | low | 0 | 0 | aromatic ether; chloride salt; quaternary ammonium salt | antibacterial agent; antifungal agent; antiseptic drug; antiviral agent; disinfectant |
peucedanin | [no description available] | low | 0 | 0 | aromatic ether; furanocoumarin; lactone | plant metabolite |
phenetidine | [no description available] | low | 0 | 0 | aromatic ether; primary amino compound; substituted aniline | drug metabolite |
6-methoxybenzoxazolinone | [no description available] | low | 0 | 0 | aromatic ether; benzoxazole | antibacterial agent; anticonvulsant; antifungal agent; muscle relaxant; plant metabolite |
3-anisidine | [no description available] | low | 0 | 0 | aromatic ether; substituted aniline | |
domiphen bromide | [no description available] | low | 0 | 0 | aromatic ether | |
dibrompropamidine | [no description available] | low | 0 | 0 | aromatic ether | |
4-Ethoxyphenol | [no description available] | low | 0 | 0 | aromatic ether; phenols | |
bulbocapnine | [no description available] | low | 0 | 0 | aporphine alkaloid; aromatic ether; oxacycle; phenols | EC 1.14.16.2 (tyrosine 3-monooxygenase) inhibitor; EC 1.4.3.22 (diamine oxidase) inhibitor; plant metabolite |
benzydamine | [no description available] | low | 0 | 0 | aromatic ether; indazoles; tertiary amino compound | analgesic; central nervous system stimulant; hallucinogen; local anaesthetic; non-steroidal anti-inflammatory drug |
xylocholine | [no description available] | low | 0 | 0 | aromatic ether | |
3-methoxycatechol | [no description available] | low | 0 | 0 | aromatic ether; catechols | G-protein-coupled receptor agonist |
2-phenoxypropanoic acid | [no description available] | low | 0 | 0 | aromatic ether; carboxylic acid | |
6-methoxyquinoline | [no description available] | low | 0 | 0 | aromatic ether; quinolines | |
metaxalone | [no description available] | low | 0 | 0 | aromatic ether | |
heliamine | [no description available] | low | 0 | 0 | aromatic ether; diether; isoquinoline alkaloid; isoquinolines | plant metabolite |
2,4,6-trichlorophenyl 4-nitrophenyl ether | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; chlorobenzenes | EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
etridiazol | [no description available] | low | 0 | 0 | aromatic ether; organochlorine compound; thiadiazole antifungal agent; thiadiazoles | antifungal agrochemical; nitrification inhibitor |
toliprolol | [no description available] | low | 0 | 0 | aromatic ether | |
5-methoxyindoleacetic acid | [no description available] | low | 0 | 0 | aromatic ether; indole-3-acetic acids | antibacterial agent; Brassica napus metabolite; carcinogenic agent; human urinary metabolite; marine xenobiotic metabolite; rat metabolite |
iproclozide | [no description available] | low | 0 | 0 | aromatic ether | |
phenoxyacetic acid | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid | allergen; Aspergillus metabolite; human xenobiotic metabolite; plant growth retardant |
nafenopin | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid | |
methyl vanillate | [no description available] | low | 0 | 0 | aromatic ether; benzoate ester; phenols | antioxidant; plant metabolite |
5-methoxyindole-2-carboxylic acid | [no description available] | low | 0 | 0 | aromatic ether; indolecarboxylic acid | EC 1.8.1.4 (dihydrolipoyl dehydrogenase) inhibitor; hypoglycemic agent; plant metabolite |
2-isopropoxyphenol | [no description available] | low | 0 | 0 | aromatic ether; phenols | |
dehydroemetine | [no description available] | low | 0 | 0 | aromatic ether; isoquinolines; pyridoisoquinoline | antileishmanial agent; antimalarial; antiprotozoal drug |
1,2-epoxy-3-(p-nitrophenoxy)propane | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; epoxide | |
laurolitsine | [no description available] | low | 0 | 0 | aporphine alkaloid; aromatic ether; phenols | HIV-1 integrase inhibitor; metabolite |
metocurine iodide | [no description available] | low | 0 | 0 | aromatic ether | |
ac 45594 | [no description available] | low | 0 | 0 | aromatic ether | |
3-phenoxybenzylalcohol | [no description available] | low | 0 | 0 | aromatic ether; benzyl alcohols | marine xenobiotic metabolite |
devrinol | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid amide; naphthalenes | |
fluorodifen | [no description available] | low | 0 | 0 | aromatic ether | |
acridine half-mustard | [no description available] | low | 0 | 0 | aminoacridines; aromatic ether; organochlorine compound; secondary amino compound | mutagen |
precocene i | [no description available] | low | 0 | 0 | aromatic ether; chromenes | plant metabolite; precocenes |
oxadiazon | [no description available] | low | 0 | 0 | aromatic ether | |
lofexidine | [no description available] | low | 0 | 0 | aromatic ether; carboxamidine; dichlorobenzene; imidazoles | alpha-adrenergic agonist; antihypertensive agent |
alclofenac | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; monochlorobenzenes | drug allergen; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
phenylglycidyl ether | [no description available] | low | 0 | 0 | aromatic ether | |
phenoxyethanol | [no description available] | low | 0 | 0 | aromatic ether; glycol ether; primary alcohol | antiinfective agent; central nervous system depressant |
metipranolol | [no description available] | low | 0 | 0 | acetate ester; aromatic ether; propanolamine; secondary amino compound | anti-arrhythmia drug; antiglaucoma drug; antihypertensive agent; beta-adrenergic antagonist |
silybin | [no description available] | low | 0 | 0 | aromatic ether; benzodioxine; flavonolignan; polyphenol; secondary alpha-hydroxy ketone | antineoplastic agent; antioxidant; hepatoprotective agent; plant metabolite |
oxamethacin | [no description available] | low | 0 | 0 | aromatic ether; hydroxamic acid; N-acylindole; organochlorine compound | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
canadine | [no description available] | low | 0 | 0 | aromatic ether; berberine alkaloid; organic heteropentacyclic compound; oxacycle | |
medifoxamine | [no description available] | low | 0 | 0 | aromatic ether | |
chlormethoxynil | [no description available] | low | 0 | 0 | aromatic ether | |
climbazole | [no description available] | low | 0 | 0 | aromatic ether; hemiaminal ether; imidazoles; ketone; monochlorobenzenes | |
4-hexyloxyaniline | [no description available] | low | 0 | 0 | aromatic ether; substituted aniline | |
ticrynafen | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; dichlorobenzene; monocarboxylic acid; thiophenes | antihypertensive agent; hepatotoxic agent; loop diuretic |
2-(4-(2,4-dichlorophenoxy)phenoxy)propionic acid | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; diether; monocarboxylic acid | |
bezafibrate | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid amide; monocarboxylic acid; monochlorobenzenes | antilipemic drug; environmental contaminant; geroprotector; xenobiotic |
oxyfluorofen | [no description available] | low | 0 | 0 | aromatic ether | EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
triadimefon | [no description available] | low | 0 | 0 | aromatic ether; hemiaminal ether; ketone; monochlorobenzenes; triazoles | |
levobunolol | [no description available] | low | 0 | 0 | aromatic ether; cyclic ketone; propanolamine | antiglaucoma drug; beta-adrenergic antagonist |
dichlorfop-methyl | [no description available] | low | 0 | 0 | aromatic ether; dichlorobenzene; diether; methyl ester | |
decamethrin | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanecarboxylate ester; nitrile; organobromine compound | agrochemical; antifeedant; calcium channel agonist; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; pyrethroid ester insecticide |
triadimenol | [no description available] | low | 0 | 0 | aromatic ether; conazole fungicide; hemiaminal ether; monochlorobenzenes; secondary alcohol; triazole fungicide | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; xenobiotic metabolite |
triclopyr | [no description available] | low | 0 | 0 | aromatic ether; chloropyridine; monocarboxylic acid | agrochemical; environmental contaminant; herbicide; xenobiotic |
prenalterol | [no description available] | low | 0 | 0 | aromatic ether | |
st 1059 | [no description available] | low | 0 | 0 | aromatic ether; primary amino compound; secondary alcohol | alpha-adrenergic agonist; sympathomimetic agent; vasoconstrictor agent |
paroxetine | [no description available] | low | 0 | 0 | aromatic ether; benzodioxoles; organofluorine compound; piperidines | antidepressant; anxiolytic drug; hepatotoxic agent; P450 inhibitor; serotonin uptake inhibitor |
acifluorfen | [no description available] | low | 0 | 0 | aromatic ether; benzoic acids; C-nitro compound; monocarboxylic acid; organochlorine compound; organofluorine compound | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
bopindolol | [no description available] | low | 0 | 0 | aromatic ether; benzoate ester; methylindole; secondary amino compound | |
fenpropathrin, (+-)-isomer | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanecarboxylate ester | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide |
triflumuron | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; monochlorobenzenes; organofluorine compound | |
flutolanil | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; benzamides; benzanilide fungicide | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor |
fenoxaprop ethyl | [no description available] | low | 0 | 0 | aromatic ether | |
triclabendazole | [no description available] | low | 0 | 0 | aromatic ether | |
4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acid | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound | environmental contaminant; herbicide; xenobiotic |
fluvalinate | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; nitrile; organochlorine acaricide; organochlorine insecticide; organofluorine acaricide; organofluorine insecticide | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide |
haloxyfop | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound; pyridines | |
fluazifop-butyl | [no description available] | low | 0 | 0 | aromatic ether; carboxylic ester; organofluorine compound; pyridines | |
fomesafen | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
fenoxycarb | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester | environmental contaminant; insecticide; juvenile hormone mimic; xenobiotic |
quizalofop-ethyl | [no description available] | low | 0 | 0 | aromatic ether; ethyl ester; organochlorine compound; quinoxaline derivative | |
cetamolol | [no description available] | low | 0 | 0 | aromatic ether | |
atomoxetine | [no description available] | low | 0 | 0 | aromatic ether; secondary amino compound; toluenes | adrenergic uptake inhibitor; antidepressant; environmental contaminant; xenobiotic |
methyl bensulfuron | [no description available] | low | 0 | 0 | aromatic ether; methyl ester; N-sulfonylurea; pyrimidines | agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide |
itraconazole | [no description available] | low | 0 | 0 | aromatic ether; conazole antifungal drug; cyclic ketal; dichlorobenzene; dioxolane; N-arylpiperazine; triazole antifungal drug; triazoles | EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; Hedgehog signaling pathway inhibitor; P450 inhibitor |
loxtidine | [no description available] | low | 0 | 0 | aromatic ether; piperidines; primary alcohol; triazoles | H2-receptor antagonist |
disoxaril | [no description available] | low | 0 | 0 | aromatic ether | |
chlorimuron ethyl | [no description available] | low | 0 | 0 | aromatic ether; ethyl ester; N-sulfonylurea; organochlorine pesticide; pyrimidines; sulfamoylbenzoate | agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; proherbicide |
tepoxalin | [no description available] | low | 0 | 0 | aromatic ether; hydroxamic acid; monochlorobenzenes; pyrazoles | antipyretic; apoptosis inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; immunomodulator; lipoxygenase inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
esmolol | [no description available] | low | 0 | 0 | aromatic ether; ethanolamines; methyl ester; secondary alcohol; secondary amino compound | |
pioglitazone hydrochloride | [no description available] | low | 0 | 0 | aromatic ether | |
aripiprazole | [no description available] | low | 0 | 0 | aromatic ether; delta-lactam; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; quinolone | drug metabolite; H1-receptor antagonist; second generation antipsychotic; serotonergic agonist |
sulfametrole | [no description available] | low | 0 | 0 | aromatic ether; substituted aniline; sulfonamide antibiotic; thiadiazoles | |
propamidine | [no description available] | low | 0 | 0 | aromatic ether; guanidines; polyether | antimicrobial agent; antiseptic drug |
hexamidine | [no description available] | low | 0 | 0 | aromatic ether; guanidines; polyether | antimicrobial agent; antiseptic drug |
o-4-methylthymine | [no description available] | low | 0 | 0 | aromatic ether; methylthymine | human metabolite |
fenclofenac | [no description available] | low | 0 | 0 | aromatic ether | |
tetraiodothyroacetic acid | [no description available] | low | 0 | 0 | 2-halophenol; aromatic ether; iodophenol; monocarboxylic acid | apoptosis inducer; human metabolite; thyroid hormone |
fluazuron | [no description available] | low | 0 | 0 | aromatic ether; chloropyridine; monochlorobenzenes; N-acylurea; organochlorine acaricide; organofluorine acaricide; phenylureas | acaricide; mite growth regulator |
etiroxate | [no description available] | low | 0 | 0 | aromatic ether | |
etofamide | [no description available] | low | 0 | 0 | aromatic ether | |
d 888 | [no description available] | low | 0 | 0 | aromatic ether; nitrile; tertiary amino compound | anti-arrhythmia drug; calcium channel blocker; vasodilator agent |
esreboxetine | [no description available] | low | 0 | 0 | aromatic ether | |
guaethol | [no description available] | low | 0 | 0 | aromatic ether; phenols; volatile organic compound | flavouring agent |
spiramide | [no description available] | low | 0 | 0 | aromatic ether; azaspiro compound; organofluorine compound; piperidines; tertiary amino compound | dopaminergic antagonist; serotonergic antagonist |
5'-nitro-2'-propoxyacetanilide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
4-methoxyestradiol | [no description available] | low | 0 | 0 | 17beta-hydroxy steroid; 3-hydroxy steroid; aromatic ether; phenols | estrogen; human metabolite; rat metabolite |
toltrazuril | [no description available] | low | 0 | 0 | aromatic ether | |
plafibride | [no description available] | low | 0 | 0 | aromatic ether | |
cinitapride | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
isoscopoletin | [no description available] | low | 0 | 0 | aromatic ether; hydroxycoumarin | plant metabolite |
ethofenprox | [no description available] | low | 0 | 0 | aromatic ether | pyrethroid ether insecticide |
uk 68798 | [no description available] | low | 0 | 0 | aromatic ether; sulfonamide; tertiary amino compound | anti-arrhythmia drug; potassium channel blocker |
hp 873 | [no description available] | low | 0 | 0 | 1,2-benzoxazoles; aromatic ether; aromatic ketone; methyl ketone; monoamine; organofluorine compound; piperidines; tertiary amino compound | dopaminergic antagonist; second generation antipsychotic; serotonergic antagonist |
fenoxypropazine | [no description available] | low | 0 | 0 | aromatic ether | |
fluphenacur | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; N-acylurea; organofluorine compound | |
amezinium | [no description available] | low | 0 | 0 | aromatic ether; primary arylamine; pyridazinium ion | adrenergic uptake inhibitor; antihypotensive agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; sympathomimetic agent |
rubrofusarin | [no description available] | low | 0 | 0 | aromatic ether; benzochromenone; phenols; polyketide | biological pigment; EC 1.14.18.1 (tyrosinase) inhibitor; fungal metabolite |
triasulfuron | [no description available] | low | 0 | 0 | 1,3,5-triazines; aromatic ether; N-sulfonylurea; organochlorine compound | agrochemical; herbicide |
dauricine | [no description available] | low | 0 | 0 | aromatic ether; bisbenzylisoquinoline alkaloid; isoquinolines; phenols; tertiary amino compound | plant metabolite |
uvaretin | [no description available] | low | 0 | 0 | aromatic ether; dihydrochalcones; polyketide; resorcinol | antineoplastic agent; plant metabolite |
fangchinoline | [no description available] | low | 0 | 0 | aromatic ether; bisbenzylisoquinoline alkaloid; macrocycle | anti-HIV-1 agent; anti-inflammatory agent; antineoplastic agent; antioxidant; neuroprotective agent; plant metabolite |
stictic acid | [no description available] | low | 0 | 0 | aromatic ether | |
pramoxine hydrochloride | [no description available] | low | 0 | 0 | aromatic ether | |
4-methoxybenzylamine | [no description available] | low | 0 | 0 | aralkylamino compound; aromatic ether; primary amino compound | |
xanthurenic acid 8-methyl ether | [no description available] | low | 0 | 0 | aromatic ether; monohydroxyquinoline; quinolinemonocarboxylic acid | carcinogenic agent; metabolite; mouse metabolite |
adriamycinol | [no description available] | low | 0 | 0 | aminoglycoside; anthracycline antibiotic; aromatic ether; deoxy hexoside; p-quinones; phenols; polyol; tetracenequinones | cardiotoxic agent; drug metabolite |
difenoconazole | [no description available] | low | 0 | 0 | aromatic ether; conazole fungicide; cyclic ketal; dioxolane; triazole fungicide; triazoles | antifungal agrochemical; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor; environmental contaminant; xenobiotic |
a 8947 | [no description available] | low | 0 | 0 | aromatic ether; biaryl; N-sulfonylurea; pyrazole pesticide; tetrazoles | EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide |
thifluzamide | [no description available] | low | 0 | 0 | 1,3-thiazoles; anilide fungicide; aromatic amide; aromatic ether; dibromobenzene; organofluorine compound | antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor |
ethylhydrocupreine | [no description available] | low | 0 | 0 | aromatic ether; cinchona alkaloid | EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor |
7,8-dihydromethysticin | [no description available] | low | 0 | 0 | 2-pyranones; aromatic ether | |
4,5-dimethoxy-2-nitrobenzaldehyde | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
bisphenol f diglycidyl ether | [no description available] | low | 0 | 0 | aromatic ether; diarylmethane; epoxide | |
oryzemate | [no description available] | low | 0 | 0 | 1,2-benzisothiazole; aromatic ether; benzothiazole fungicide; sulfone | antifungal agrochemical; plant activator |
bitertanol | [no description available] | low | 0 | 0 | aromatic ether; biphenyls; secondary alcohol; triazoles | |
fluazifop | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; organofluorine compound; pyridines | |
diflufenican | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; pyridinecarboxamide | carotenoid biosynthesis inhibitor; environmental contaminant; herbicide; xenobiotic |
hexafluoron | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; N-acylurea; organochlorine insecticide; organofluorine insecticide | |
diethofencarb | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester; carbanilate fungicide | antifungal agrochemical |
pyriproxyfen | [no description available] | low | 0 | 0 | aromatic ether; pyridines | juvenile hormone mimic |
methyl 2-(((((4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)benzoate | [no description available] | low | 0 | 0 | aromatic ether; benzoate ester; diamino-1,3,5-triazine; methyl ester; N-sulfonylurea | EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide |
dpx e9636 | [no description available] | low | 0 | 0 | aromatic ether; N-sulfonylurea; pyridines; pyrimidines; sulfone | environmental contaminant; herbicide; xenobiotic |
aclonifen | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; monochlorobenzenes; primary amino compound; substituted aniline | agrochemical; carotenoid biosynthesis inhibitor; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
cinosulfuron | [no description available] | low | 0 | 0 | aromatic ether | |
clodinafop-propargyl | [no description available] | low | 0 | 0 | aromatic ether; carboxylic ester; organochlorine compound; organofluorine compound; propyzamide; pyridines | agrochemical; EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; herbicide |
triflusulfuron-methyl | [no description available] | low | 0 | 0 | 1,3,5-triazines; aromatic ether; benzoate ester; methyl ester; N-sulfonylurea; organofluorine compound; tertiary amino compound | agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; proherbicide |
vestitol | [no description available] | low | 0 | 0 | aromatic ether; hydroxyisoflavans; methoxyisoflavan | anti-inflammatory agent; phytoalexin; plant metabolite |
laudanine | [no description available] | low | 0 | 0 | aromatic ether; benzylisoquinoline alkaloid; benzyltetrahydroisoquinoline; phenols; racemate | |
cryptopleurine | [no description available] | low | 0 | 0 | alkaloid antibiotic; alkaloid; aromatic ether; organic heteropentacyclic compound | antineoplastic agent; antiviral agent; protein synthesis inhibitor |
6-hydroxymethylmexiletine | [no description available] | low | 0 | 0 | aromatic ether | |
4-hydroxymexiletine | [no description available] | low | 0 | 0 | aromatic ether; phenols | |
cloquintocet-mexyl | [no description available] | low | 0 | 0 | aromatic ether; carboxylic ester; organochlorine compound; quinolines | |
novaluron | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; monochlorobenzenes; organofluorine compound | |
bursehernin | [no description available] | low | 0 | 0 | aromatic ether; benzodioxoles; butan-4-olide; lignan | plant metabolite |
2,2',4,4'-tetrabromodiphenyl ether | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound | |
allocryptopine | [no description available] | low | 0 | 0 | aromatic ether; cyclic acetal; cyclic ketone; dibenzazecine alkaloid; organic heterotetracyclic compound; tertiary amino compound | |
sporidesmin | [no description available] | low | 0 | 0 | aromatic ether; cyclic ketone; diketone; organic disulfide; organic heteropentacyclic compound; organochlorine compound; secondary alcohol; tertiary alcohol; tertiary amino compound | mycotoxin; Wnt signalling activator |
syringaresinol | [no description available] | low | 0 | 0 | aromatic ether; furofuran; lignan; polyether; polyphenol | plant metabolite |
p-methoxy-n-methylphenethylamine | [no description available] | low | 0 | 0 | aromatic ether; secondary amino compound | metabolite |
aflatoxin q1 | [no description available] | low | 0 | 0 | aflatoxin; aromatic ether; aromatic ketone | carcinogenic agent; human xenobiotic metabolite |
u 73122 | [no description available] | low | 0 | 0 | aromatic ether; aza-steroid; maleimides | EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor |
cyfluthrin | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound | agrochemical; pyrethroid ester insecticide |
norverapamil | [no description available] | low | 0 | 0 | aromatic ether; nitrile; polyether; secondary amino compound | |
fumitremorgin a | [no description available] | low | 0 | 0 | aromatic ether; diol; indole alkaloid; organic heterohexacyclic compound; organic peroxide | mycotoxin |
deguelin | [no description available] | low | 0 | 0 | aromatic ether; diether; organic heteropentacyclic compound; rotenones | angiogenesis inhibitor; anti-inflammatory agent; antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; mitochondrial NADH:ubiquinone reductase inhibitor; plant metabolite |
aristolochic acid ii | [no description available] | low | 0 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin |
tephrosin | [no description available] | low | 0 | 0 | aromatic ether; cyclic ketone; organic heteropentacyclic compound; rotenones | antineoplastic agent; metabolite; pesticide |
alpha-hydroxymetoprolol | [no description available] | low | 0 | 0 | aromatic ether | |
5-(tetradecyloxy)-2-furancarboxylic acid | [no description available] | low | 0 | 0 | aromatic ether; furoic acid | antineoplastic agent; apoptosis inducer; EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; PPARalpha agonist |
tafenoquine | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aminoquinoline; aromatic ether; primary amino compound; secondary amino compound | |
5-hydroxymethylomeprazole | [no description available] | low | 0 | 0 | aromatic ether; benzimidazoles; pyridines; sulfoxide | drug metabolite |
mosapride | [no description available] | low | 0 | 0 | aromatic ether; benzamides; monochlorobenzenes; monofluorobenzenes; morpholines; secondary carboxamide; substituted aniline; tertiary amino compound | |
ym 12617 | [no description available] | low | 0 | 0 | aromatic ether; secondary amino compound; sulfonamide | |
gefitinib | [no description available] | low | 0 | 0 | aromatic ether; monochlorobenzenes; monofluorobenzenes; morpholines; quinazolines; secondary amino compound; tertiary amino compound | antineoplastic agent; epidermal growth factor receptor antagonist |
cgp 28392 | [no description available] | low | 0 | 0 | aromatic ether | |
sodium-binding benzofuran isophthalate | [no description available] | low | 0 | 0 | 1-benzofurans; aromatic ether; crown compound; tetracarboxylic acid | fluorochrome |
garenoxacin | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanes; isoindoles; organofluorine compound; quinolinemonocarboxylic acid; quinolone antibiotic | antibacterial drug; non-steroidal anti-inflammatory drug |
ay 25545 | [no description available] | low | 0 | 0 | acetate ester; aromatic ether; C-glycosyl compound; naphthoisochromene; olefinic compound; phenols; tertiary amine | antimicrobial agent; antineoplastic agent; bacterial metabolite |
reboxetine | [no description available] | low | 0 | 0 | aromatic ether | |
b 823-08 | [no description available] | low | 0 | 0 | aromatic ether | |
cyclazosin | [no description available] | low | 0 | 0 | aromatic amide; aromatic ether; furans; monocarboxylic acid amide; quinazolines; quinoxaline derivative | adenosine A2A receptor antagonist |
ivabradine | [no description available] | low | 0 | 0 | aromatic ether; benzazepine; carbobicyclic compound; tertiary amino compound | cardiotonic drug |
febuxostat | [no description available] | low | 0 | 0 | 1,3-thiazolemonocarboxylic acid; aromatic ether; nitrile | EC 1.17.3.2 (xanthine oxidase) inhibitor |
marsupsin | [no description available] | low | 0 | 0 | 1-benzofurans; aromatic ether; polyphenol | antilipemic drug; hypoglycemic agent; metabolite |
6,6'-bieckol | [no description available] | low | 0 | 0 | aromatic ether; oxacycle; phlorotannin | anti-HIV-1 agent; metabolite; radical scavenger |
xibenolol | [no description available] | low | 0 | 0 | aromatic ether | |
cicloprolol | [no description available] | low | 0 | 0 | aromatic ether | |
chs 828 | [no description available] | low | 0 | 0 | aromatic ether | |
2-(4-methoxyphenoxy)propanoic acid | [no description available] | low | 0 | 0 | aromatic ether; carboxylic acid | |
moxifloxacin | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanes; fluoroquinolone antibiotic; pyrrolidinopiperidine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone | antibacterial drug |
rp 73401 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; chloropyridine; monocarboxylic acid amide | anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; phosphodiesterase IV inhibitor |
2,2',4,4',5,5'-hexabrominated diphenyl ether | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound | |
varespladib | [no description available] | low | 0 | 0 | aromatic ether; benzenes; dicarboxylic acid monoamide; indoles; monocarboxylic acid; primary carboxamide | anti-inflammatory drug; antidote; EC 3.1.1.4 (phospholipase A2) inhibitor |
birb 796 | [no description available] | low | 0 | 0 | aromatic ether; morpholines; naphthalenes; pyrazoles; ureas | EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; immunomodulator |
schizandrin b | [no description available] | low | 0 | 0 | aromatic ether; cyclic acetal; organic heterotetracyclic compound; oxacycle; tannin | anti-asthmatic agent; anti-inflammatory agent; antilipemic drug; antioxidant; apoptosis inhibitor; hepatoprotective agent; nephroprotective agent; neuroprotective agent; plant metabolite |
s 23121 | [no description available] | low | 0 | 0 | aromatic ether; dicarboximide; monochlorobenzenes; monofluorobenzenes; pyrroline; terminal acetylenic compound | |
acrovestone | [no description available] | low | 0 | 0 | acetophenones; aromatic ether; olefinic compound; polyphenol | antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; plant metabolite |
corytuberine | [no description available] | low | 0 | 0 | aporphine alkaloid; aromatic ether; organic heterotetracyclic compound; polyphenol; tertiary amino compound | plant metabolite |
actinodaphine | [no description available] | low | 0 | 0 | aporphine alkaloid; aromatic ether; organic heteropentacyclic compound; phenols; secondary amino compound | antibacterial agent; antifungal agent; antineoplastic agent; apoptosis inducer; plant metabolite; platelet aggregation inhibitor; topoisomerase inhibitor |
isohomovanillic acid | [no description available] | low | 0 | 0 | aromatic ether; phenols; phenylacetic acids | metabolite |
3,5-diiodothyropropionic acid | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; organoiodine compound; phenols | |
7,8-dihydro-5,6-dehydrokawain | [no description available] | low | 0 | 0 | 2-pyranones; aromatic ether | |
4-amino-2-methoxypyrimidine | [no description available] | low | 0 | 0 | aminopyrimidine; aromatic ether; methylcytosine | metabolite |
aristolochic acid D | [no description available] | low | 0 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; nephrotoxin; toxin |
myricanone | [no description available] | low | 0 | 0 | aromatic ether; cyclic ketone; diarylheptanoid; methoxybenzenes; phenols | antineoplastic agent; plant metabolite |
pannarin | [no description available] | low | 0 | 0 | aldehyde; aromatic ether; depsidones; organic heterotricyclic compound; organochlorine compound; phenols | antimicrobial agent; antineoplastic agent; apoptosis inducer; lichen metabolite |
aminopotentidine | [no description available] | low | 0 | 0 | aromatic ether; benzamides; guanidines; nitrile; piperidines; substituted aniline | H2-receptor antagonist |
aristolochic acid c | [no description available] | low | 0 | 0 | aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound | carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin |
pluviatolide | [no description available] | low | 0 | 0 | aromatic ether; benzodioxoles; butan-4-olide; lignan; phenols | plant metabolite |
erysodine | [no description available] | low | 0 | 0 | aromatic ether; diether; Erythrina alkaloid; organic heterotetracyclic compound; phenols | antiparasitic agent; nicotinic antagonist; phytogenic insecticide |
erlotinib | [no description available] | low | 0 | 0 | aromatic ether; quinazolines; secondary amino compound; terminal acetylenic compound | antineoplastic agent; epidermal growth factor receptor antagonist; protein kinase inhibitor |
rubrofusarin B | [no description available] | low | 0 | 0 | aromatic ether; benzochromenone; naphtho-gamma-pyrone; phenols; polyketide | Aspergillus metabolite |
ly 293111 | [no description available] | low | 0 | 0 | aromatic ether | |
enrasentan | [no description available] | low | 0 | 0 | aromatic ether; benzodioxoles; indanes; monocarboxylic acid; monomethoxybenzene; primary alcohol | antihypertensive agent; endothelin receptor antagonist |
quizalofop | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; organochlorine compound; quinoxaline derivative | |
cyhalofop-butyl | [no description available] | low | 0 | 0 | aromatic ether | |
cyperin | [no description available] | low | 0 | 0 | aromatic ether | |
aflatoxin b1 | [no description available] | low | 0 | 0 | aflatoxin; aromatic ether; aromatic ketone | carcinogenic agent; human metabolite |
etravirine | [no description available] | low | 0 | 0 | aminopyrimidine; aromatic ether; dinitrile; organobromine compound | antiviral agent; HIV-1 reverse transcriptase inhibitor |
5-o-methyllicoricidin | [no description available] | low | 0 | 0 | aromatic ether; hydroxyisoflavans; methoxyisoflavan | antibacterial agent; plant metabolite |
pronuciferine | [no description available] | low | 0 | 0 | aromatic ether; cyclic ketone; isoquinoline alkaloid; isoquinolines; organic heterotetracyclic compound | plant metabolite |
famoxadone | [no description available] | low | 0 | 0 | aromatic ether; carbohydrazide; oxazolidinone | |
cimicoxib | [no description available] | low | 0 | 0 | aromatic ether; imidazoles; organochlorine compound; organofluorine compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
sorafenib | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; phenylureas; pyridinecarboxamide | angiogenesis inhibitor; anticoronaviral agent; antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; ferroptosis inducer; tyrosine kinase inhibitor |
dabuzalgron | [no description available] | low | 0 | 0 | aromatic ether; imidazoles; monochlorobenzenes; sulfonamide | alpha-adrenergic agonist |
fonsecin | [no description available] | low | 0 | 0 | aromatic ether; cyclic hemiketal; heptaketide; naphtho-gamma-pyrone; phenols | Aspergillus metabolite; marine metabolite |
lasofoxifene | [no description available] | low | 0 | 0 | aromatic ether; N-alkylpyrrolidine; naphthols; tetralins | antineoplastic agent; bone density conservation agent; cardioprotective agent; estrogen receptor agonist; estrogen receptor antagonist |
(+-)-Dihydromethysticin | [no description available] | low | 0 | 0 | 2-pyranones; aromatic ether | |
2-[2-[2-(2-aminophenoxy)ethoxy]ethoxy]aniline | [no description available] | low | 0 | 0 | aromatic ether; substituted aniline | |
chondocurine (1beta)-(+-)-isomer | [no description available] | low | 0 | 0 | aromatic ether | |
1-methyl-4-prop-2-enoxy-2-pyrimidinone | [no description available] | low | 0 | 0 | aromatic ether; pyrimidone | |
noscapine | [no description available] | low | 0 | 0 | aromatic ether; benzylisoquinoline alkaloid; cyclic acetal; isobenzofuranone; organic heterobicyclic compound; organic heterotricyclic compound; tertiary amino compound | antineoplastic agent; antitussive; apoptosis inducer; plant metabolite |
4-[4-(3-methyl-4-nitrophenoxy)butoxy]benzonitrile | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
lariciresinol | [no description available] | low | 0 | 0 | aromatic ether; lignan; oxolanes; phenols; primary alcohol | antifungal agent; plant metabolite |
tryptoquivaline | [no description available] | low | 0 | 0 | aromatic ether; indole alkaloid; organic heteropentacyclic compound | breast cancer resistance protein inhibitor; mycotoxin |
2-methoxyestrone | [no description available] | low | 0 | 0 | 17-oxo steroid; 3-hydroxy steroid; alicyclic ketone; aromatic ether; phenolic steroid; phenols | human metabolite; mouse metabolite |
win 54954 | [no description available] | low | 0 | 0 | aromatic ether | |
silychristin | [no description available] | low | 0 | 0 | 1-benzofurans; aromatic ether; flavonolignan; polyphenol; secondary alpha-hydroxy ketone | lipoxygenase inhibitor; metabolite; prostaglandin antagonist; radical scavenger |
cleomiscosin a | [no description available] | low | 0 | 0 | aromatic ether; delta-lactone; organic heterotricyclic compound; phenols; primary alcohol | anti-inflammatory agent; metabolite |
bispyribac | [no description available] | low | 0 | 0 | aromatic ether; benzoic acids; monocarboxylic acid; pyrimidines | herbicide |
petunidin-3-glucoside | [no description available] | low | 0 | 0 | anthocyanin cation; aromatic ether; beta-D-glucoside | antioxidant; metabolite |
malvidin-3-glucoside | [no description available] | low | 0 | 0 | anthocyanin cation; aromatic ether; beta-D-glucoside | metabolite |
dioncophylline c | [no description available] | low | 0 | 0 | aromatic ether; biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes; naphthols | antimalarial; antiplasmodial drug; metabolite |
stigmatellin | [no description available] | low | 0 | 0 | aromatic ether; chromones; olefinic compound; phenols | bacterial metabolite; quinol oxidation site inhibitor |
roflumilast | [no description available] | low | 0 | 0 | aromatic ether; benzamides; chloropyridine; cyclopropanes; organofluorine compound | anti-asthmatic drug; phosphodiesterase IV inhibitor |
teniposide | [no description available] | low | 0 | 0 | aromatic ether; beta-D-glucoside; cyclic acetal; furonaphthodioxole; gamma-lactone; monosaccharide derivative; phenols; thiophenes | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
prinomastat | [no description available] | low | 0 | 0 | aromatic ether; hydroxamic acid; pyridines; sulfonamide; thiomorpholines | antineoplastic agent; EC 3.4.24.35 (gelatinase B) inhibitor; matrix metalloproteinase inhibitor |
posaconazole | [no description available] | low | 0 | 0 | aromatic ether; conazole antifungal drug; N-arylpiperazine; organofluorine compound; oxolanes; triazole antifungal drug; triazoles | trypanocidal drug |
gancaonin I | [no description available] | low | 0 | 0 | 1-benzofurans; aromatic ether; resorcinols | antibacterial agent; plant metabolite |
glyasperin D | [no description available] | low | 0 | 0 | aromatic ether; hydroxyisoflavans; methoxyisoflavan | plant metabolite |
licoricidin | [no description available] | low | 0 | 0 | aromatic ether; hydroxyisoflavans; methoxyisoflavan | antibacterial agent; plant metabolite |
egonol | [no description available] | low | 0 | 0 | 1-benzofurans; aromatic ether; benzodioxoles; primary alcohol | plant metabolite |
N-ethylharmine | [no description available] | low | 0 | 0 | aromatic ether; beta-carbolines; semisynthetic derivative | anti-HIV agent |
pf 1163a | [no description available] | low | 0 | 0 | aromatic ether; lactam; macrolide antibiotic; secondary alcohol | antifungal agent; Penicillium metabolite |
pf 1163b | [no description available] | low | 0 | 0 | aromatic ether; lactam; macrolide antibiotic | antifungal agent; Penicillium metabolite |
licocoumarone | [no description available] | low | 0 | 0 | 1-benzofurans; aromatic ether; resorcinols | antibacterial agent; apoptosis inducer; EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite |
4-(4-chloro-2-methylphenoxy)-n-hydroxybutanamide | [no description available] | low | 0 | 0 | aromatic ether | |
LSM-22807 | [no description available] | low | 0 | 0 | aromatic ether | |
N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
piperlactam s | [no description available] | low | 0 | 0 | alkaloid; aromatic ether; gamma-lactam; organic heterotetracyclic compound; phenols | anti-inflammatory agent; antioxidant; plant metabolite |
5,5-dioxo-1-(4-phenoxyphenyl)-3a,4,6,6a-tetrahydro-3H-thieno[3,4-b]pyrrol-2-one | [no description available] | low | 0 | 0 | aromatic ether | |
antofine | [no description available] | low | 0 | 0 | alkaloid antibiotic; alkaloid; aromatic ether; organic heteropentacyclic compound | angiogenesis inhibitor; anti-inflammatory agent; antimicrobial agent; antineoplastic agent; antiviral agent; phytotoxin; plant metabolite |
2-phenoxy-N-(2-pyridinyl)butanamide | [no description available] | low | 0 | 0 | aromatic ether | |
6-amino-4-(2-ethoxyphenyl)-3-propyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | low | 0 | 0 | aromatic ether; pyranopyrazole | |
N-[4-[4-[[1-oxo-2-(1-pyrrolidinyl)ethyl]amino]phenoxy]phenyl]-2-(1-pyrrolidinyl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
2-(3,4-diethoxyphenyl)-5-(2-furanyl)-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | aromatic ether | |
2-[[5-(phenoxymethyl)-4-(2-phenylethyl)-1,2,4-triazol-3-yl]thio]acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
1-(8-methyl-2,5,11,14-tetraoxa-8-azabicyclo[13.4.0]nonadeca-1(15),16,18-trien-17-yl)ethanol | [no description available] | low | 0 | 0 | aromatic ether | |
3-[2-(3-phenoxypropyl)-5-tetrazolyl]pyridine | [no description available] | low | 0 | 0 | aromatic ether | |
1-cyclohexyl-5-(2-phenoxyethylthio)tetrazole | [no description available] | low | 0 | 0 | aromatic ether | |
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-[[5-[(3-methylphenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
6-amino-4-[3-ethoxy-4-[2-(4-morpholinyl)ethoxy]phenyl]-3-ethyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | low | 0 | 0 | aromatic ether; pyranopyrazole | |
2-[[5-[(2,3-dimethylphenoxy)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-1-thiophen-2-ylethanone | [no description available] | low | 0 | 0 | aromatic ether | |
(1-methyl-2-imidazolyl)-(4-phenylmethoxyphenyl)methanol | [no description available] | low | 0 | 0 | aromatic ether | |
5-(3-butoxyphenyl)-1,3,4-thiadiazol-2-amine | [no description available] | low | 0 | 0 | aromatic ether | |
3-(2-ethoxy-6-methyl-3-pyridinyl)-5-(2-pyridinyl)-1,2,4-oxadiazole | [no description available] | low | 0 | 0 | aromatic ether | |
6-(3,4,5-triethoxyphenyl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole | [no description available] | low | 0 | 0 | aromatic ether; triazolothiadiazole | |
4-(1-benzotriazolyl)-5-(2-methoxyphenoxy)benzene-1,2-dicarbonitrile | [no description available] | low | 0 | 0 | aromatic ether | |
4-cyclohexyl-3-[(3-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione | [no description available] | low | 0 | 0 | aromatic ether | |
7-ethoxy-9-nitro-5H-benzo[b][1,4]benzoxazepin-6-one | [no description available] | low | 0 | 0 | aromatic ether | |
4-[4-(2-quinoxalinyl)phenoxy]benzene-1,2-dicarbonitrile | [no description available] | low | 0 | 0 | aromatic ether | |
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-(phenoxymethyl)-4-triazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | aromatic ether | |
2-(4-ethylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
2-(4-chloro-3-methylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
5-[(4-ethylphenoxy)methyl]-N-(2-pyridinylmethyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
7-methoxy-3,5-dimethyl-2-thiazolo[4,5-d]pyrimidinethione | [no description available] | low | 0 | 0 | aromatic ether | |
N-[4-(4-ethylphenyl)-2-thiazolyl]carbamic acid phenyl ester | [no description available] | low | 0 | 0 | aromatic ether | |
2-(2-bromo-4-methylphenoxy)-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
1-[[3-(4-chlorophenoxy)phenyl]methyl]-4-ethylpiperazine | [no description available] | low | 0 | 0 | aromatic ether | |
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
4-[[4-(ethylamino)-6-(methylthio)-1,3,5-triazin-2-yl]oxy]benzoic acid ethyl ester | [no description available] | low | 0 | 0 | aromatic ether | |
5-ethyl-3-[[4-(2-methylpropoxy)phenyl]methylthio]-1H-1,2,4-triazole | [no description available] | low | 0 | 0 | aromatic ether | |
[4-[(2-fluorophenyl)methoxy]phenyl]-(1-pyrrolidinyl)methanethione | [no description available] | low | 0 | 0 | aromatic ether | |
5-[(2-chlorophenoxy)methyl]-3-pyridin-4-yl-1,2,4-oxadiazole | [no description available] | low | 0 | 0 | aromatic ether | |
4-(4-phenylmethoxyphenyl)thiadiazole | [no description available] | low | 0 | 0 | aromatic ether | |
N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
2-[[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(4-morpholinyl)ethanone | [no description available] | low | 0 | 0 | aromatic ether | |
4-(3-pyridinyloxy)benzene-1,2-dicarbonitrile | [no description available] | low | 0 | 0 | aromatic ether | |
N-tert-butyl-2-(4-chloro-3-methylphenoxy)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
1-(2-furanylmethyl)-3-(4-phenoxyphenyl)thiourea | [no description available] | low | 0 | 0 | aromatic ether | |
1-(2-methylpropyl)-3-(4-phenoxyphenyl)thiourea | [no description available] | low | 0 | 0 | aromatic ether | |
1-cyclopentyl-3-(4-phenoxyphenyl)thiourea | [no description available] | low | 0 | 0 | aromatic ether | |
5-[(4-ethoxyphenoxy)methyl]-N-(3-pyridinyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
2-(2,3-dimethylphenoxy)-N-pyridin-4-ylacetamide | [no description available] | low | 0 | 0 | aromatic ether | |
5-[(2-chlorophenoxy)methyl]-N-(2-thiazolyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
N-(4,5-dihydrothiazol-2-yl)-2-(2-methylphenoxy)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
5-(2-fluorophenoxy)-1-methyl-3-nitro-1,2,4-triazole | [no description available] | low | 0 | 0 | aromatic ether | |
1-methyl-5-(1-naphthalenyloxy)-4-nitroimidazole | [no description available] | low | 0 | 0 | aromatic ether | |
curcumin | [no description available] | low | 0 | 0 | aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol | anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger |
1-(3,4-dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
1-cyclopentyl-3-(2-phenoxyphenyl)thiourea | [no description available] | low | 0 | 0 | aromatic ether | |
N-(1-ethyl-2-benzimidazolyl)-5-[(4-methyl-2-nitrophenoxy)methyl]-2-furancarboxamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
2-chloro-12-(4-methoxyphenyl)sulfonylquinoxalino[2,3-b][1,4]benzoxazine | [no description available] | low | 0 | 0 | aromatic ether | |
1-(3-methoxy-5-nitrophenyl)-3-(4-methylphenyl)urea | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
2-(2-bromo-4-chlorophenoxy)-N-cyclohexyl-N-methylacetamide | [no description available] | low | 0 | 0 | aromatic ether | |
2-furanyl-[4-(4-phenoxyphenyl)sulfonyl-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | aromatic ether | |
4-(2-methoxyphenoxy)-N-(3-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | aromatic ether | |
1-(3-chlorophenyl)-3-(2-phenoxyphenyl)thiourea | [no description available] | low | 0 | 0 | aromatic ether | |
N-[3-[2-(1-azepanyl)-4,5-dicyanophenoxy]phenyl]acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
2,5-dimethoxy-N-(4-phenoxyphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | aromatic ether | |
4-[[4-(dimethylamino)-6-(4-morpholinyl)-1,3,5-triazin-2-yl]oxy]benzoic acid methyl ester | [no description available] | low | 0 | 0 | aromatic ether | |
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-5-methyl-3-phenyl-4-isoxazolecarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
1-[4-[[4-(2-chloro-6-nitrophenoxy)phenyl]methoxy]phenyl]ethanone | [no description available] | low | 0 | 0 | aromatic ether | |
N-[4-[[2-(4-hydroxyphenyl)-1,3-dioxo-5-isoindolyl]oxy]phenyl]-2,2-dimethylpropanamide | [no description available] | low | 0 | 0 | aromatic ether | |
N-[[4-(4-chlorophenoxy)anilino]-sulfanylidenemethyl]benzamide | [no description available] | low | 0 | 0 | aromatic ether | |
2-(4-fluorophenoxy)-N-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
4-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]oxy]-N-propan-2-ylbenzenesulfonamide | [no description available] | low | 0 | 0 | aromatic ether | |
4-(4-tert-butylphenoxy)-5-methoxy-2-phenylpyrimidine | [no description available] | low | 0 | 0 | aromatic ether | |
4-phenoxy-2-phenyl-5-pyrimidinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | aromatic ether | |
Src Inhibitor-1 | [no description available] | low | 0 | 0 | aromatic ether; polyether; quinazolines; secondary amino compound | EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
N-[2,5-dioxo-6-(4-phenoxyphenyl)-3-pyrano[3,2-c]pyridinyl]benzamide | [no description available] | low | 0 | 0 | aromatic ether | |
2-(4-chlorophenoxy)-4-(dimethylamino)-3-pyridinecarbonitrile | [no description available] | low | 0 | 0 | aromatic ether | |
6-methyl-5-[2-(2-methylphenoxy)ethyl]-2-sulfanylidene-1H-pyrimidin-4-one | [no description available] | low | 0 | 0 | aromatic ether | |
4-(4-chlorophenoxy)-1-(4-morpholinyl)-1-butanone | [no description available] | low | 0 | 0 | aromatic ether | |
N4-ethyl-6-[2-(4-methylphenoxy)ethylthio]-N2-propan-2-yl-1,3,5-triazine-2,4-diamine | [no description available] | low | 0 | 0 | aromatic ether | |
4-(phenylmethyl)-3-[2-(4-propoxyphenyl)ethyl]-1H-1,2,4-triazole-5-thione | [no description available] | low | 0 | 0 | aromatic ether | |
1-[[1-oxo-3-(4-propan-2-yloxyphenyl)propyl]amino]-3-(phenylmethyl)thiourea | [no description available] | low | 0 | 0 | aromatic ether | |
N-[3-(3-methylphenoxy)-5-nitrophenyl]-2-(3-nitro-1,2,4-triazol-1-yl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
N-bis(2-fluorophenoxy)phosphoryl-3,4-dimethylaniline | [no description available] | low | 0 | 0 | aromatic ether | |
2-[[4-(2-ethoxyanilino)-6-(4-ethoxyanilino)-2-pyrimidinyl]methylidene]propanedinitrile | [no description available] | low | 0 | 0 | aromatic ether | |
5-methyl-3-[(4-pentoxyphenyl)methylthio]-1H-1,2,4-triazole | [no description available] | low | 0 | 0 | aromatic ether | |
4,5-dichloro-1-[2-(4-chlorophenoxy)ethyl]imidazole | [no description available] | low | 0 | 0 | aromatic ether | |
1-butyl-3-(4-phenoxyphenyl)thiourea | [no description available] | low | 0 | 0 | aromatic ether | |
N-(3-cyano-2-thiophenyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
2-(2-bromophenyl)-5-[(2-chlorophenoxy)methyl]-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | aromatic ether | |
5-(4-ethoxyphenyl)-N-(3,4,5,6-tetrahydro-2H-azepin-7-yl)-1,3,4-oxadiazol-2-amine | [no description available] | low | 0 | 0 | aromatic ether | |
4-(4-chloro-2-methylphenoxy)-1-(4-morpholinyl)-1-butanone | [no description available] | low | 0 | 0 | aromatic ether | |
N9-(4-butoxyphenyl)-6,8,10-triazaspiro[4.5]deca-6,9-diene-7,9-diamine | [no description available] | low | 0 | 0 | aromatic ether | |
2-[2-(4-chlorophenoxy)ethylthio]pyrimidine | [no description available] | low | 0 | 0 | aromatic ether | |
5-(3-phenoxypropyl)-3-(3-pyridinyl)-1,2,4-oxadiazole | [no description available] | low | 0 | 0 | aromatic ether | |
N-[(3-ethoxy-2-prop-2-enoxyphenyl)methyl]-2-thiazolamine | [no description available] | low | 0 | 0 | aromatic ether | |
2-(2-bromophenoxy)-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
4-[2-[(4-chlorophenyl)thio]ethoxy]-3-ethoxybenzaldehyde | [no description available] | low | 0 | 0 | aromatic ether | |
1-(3-fluorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrophenyl)-4H-pyridine-3,5-dicarboxylic acid diethyl ester | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
5-(2-ethoxyphenyl)-3H-1,3,4-oxadiazole-2-thione | [no description available] | low | 0 | 0 | aromatic ether | |
N-tert-butyl-4-(2-fluorophenoxy)-1-butanamine | [no description available] | low | 0 | 0 | aromatic ether | |
N-butyl-4-phenoxy-1-butanamine | [no description available] | low | 0 | 0 | aromatic ether | |
N-[3-[[diethylamino(sulfanylidene)methyl]thio]-1-oxopropyl]carbamic acid (4-methylphenyl) ester | [no description available] | low | 0 | 0 | aromatic ether | |
1,3-dimethyl-5-[[2-[2-(4-nitrophenoxy)ethoxy]phenyl]methylidene]-1,3-diazinane-2,4,6-trione | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
4-[2-[2-(4-bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine | [no description available] | low | 0 | 0 | aromatic ether | |
2-[2-(3-ethylphenoxy)ethyl]propanedioic acid diethyl ester | [no description available] | low | 0 | 0 | aromatic ether | |
2,3-dihydro-1,4-dioxin-5-carboxylic acid [2-[4-[4-(2-methylbutan-2-yl)phenoxy]anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | aromatic ether | |
1-[3-(2-bromo-4-chlorophenoxy)propyl]-4-methylpiperidine | [no description available] | low | 0 | 0 | aromatic ether | |
N4-(2-methoxyphenyl)benzene-1,4-diamine | [no description available] | low | 0 | 0 | aromatic ether; substituted aniline | |
4-(1H-benzimidazol-2-ylthio)butanoic acid [2-oxo-2-(4-phenoxyanilino)ethyl] ester | [no description available] | low | 0 | 0 | aromatic ether | |
2-phenoxybenzoic acid [2-(2-furanylmethylamino)-2-oxoethyl] ester | [no description available] | low | 0 | 0 | aromatic ether | |
1-[2,5-dimethyl-1-(phenylmethyl)-3-pyrrolyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone | [no description available] | low | 0 | 0 | aromatic ether | |
N-[6-amino-1-(2-methylpropyl)-2,4-dioxo-5-pyrimidinyl]-2-(2-methylphenoxy)-N-(2-methylpropyl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
4-[[6-[(2-methyl-5-thieno[2,3-e][1,3]benzothiazolyl)oxy]-3-pyridinyl]sulfonyl]morpholine | [no description available] | low | 0 | 0 | aromatic ether | |
5-(3-fluorophenoxy)-8-nitroisoquinoline | [no description available] | low | 0 | 0 | aromatic ether | |
1-[4-(2-prop-2-enylphenoxy)butyl]pyrrolidine | [no description available] | low | 0 | 0 | aromatic ether | |
2-(2,4-dibromophenoxy)-N-[oxo-(propan-2-ylamino)methyl]acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
4-phenoxyphenyl 4-hydroxypiperidine-1-carboxylate | [no description available] | low | 0 | 0 | aromatic ether | |
N'-benzoyl-5-(3,5-dichlorophenoxy)-2-furancarbohydrazide | [no description available] | low | 0 | 0 | aromatic ether | |
1-[2-[(4-chlorophenoxy)methyl]-4-thiazolyl]ethanone | [no description available] | low | 0 | 0 | aromatic ether | |
5-(benzyloxy)-2-(hydroxymethyl)-1,4-dihydropyridin-4-one | [no description available] | low | 0 | 0 | aromatic ether | |
2-(4-aminophenoxy)isophthalonitrile | [no description available] | low | 0 | 0 | aromatic ether | |
N5-(2-chloro-6-phenoxybenzyl)-1H-1,2,4-triazole-3,5-diamine | [no description available] | low | 0 | 0 | aromatic ether | |
N-[(2-chloro-6-phenoxyphenyl)methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | aromatic ether | |
N-[5-(tert-butyl)-3-isoxazolyl]-N'-[2-(trifluoromethoxy)phenyl]urea | [no description available] | low | 0 | 0 | aromatic ether | |
6-(4-methoxyphenoxy)-2-imidazo[1,2-b]pyridazinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | aromatic ether | |
2-fluoro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]acetamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
2-amino-4-(4,5-dimethoxy-2-nitrophenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbonitrile | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
2,4-dichloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
1-anilino-3-[4-(3-anilino-2-hydroxypropoxy)phenoxy]-2-propanol | [no description available] | low | 0 | 0 | aromatic ether | |
1-[4-(3-ethoxyphenoxy)butyl]imidazole | [no description available] | low | 0 | 0 | aromatic ether | |
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-oxolanecarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
1-[[2-(2,4-difluorophenoxy)-1-oxopropyl]amino]-3-(2-oxolanylmethyl)thiourea | [no description available] | low | 0 | 0 | aromatic ether | |
N-[[(5-bromo-6-methyl-2-pyridinyl)amino]-sulfanylidenemethyl]-2-(2-chlorophenoxy)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
4-oxido-3-(4-phenoxyphenyl)-4a,5,6,7,8,8a-hexahydroquinoxalin-1-ium 1-oxide | [no description available] | low | 0 | 0 | aromatic ether | |
1-(2-fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
2-[[5-[(2-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
cyclopropanecarboxylic acid [2-oxo-2-(4-phenoxyanilino)ethyl] ester | [no description available] | low | 0 | 0 | aromatic ether | |
toremifene | [no description available] | low | 0 | 0 | aromatic ether; organochlorine compound; tertiary amine | antineoplastic agent; bone density conservation agent; estrogen antagonist; estrogen receptor modulator |
dieckol | [no description available] | low | 0 | 0 | aromatic ether; oxacycle; phlorotannin | anticoagulant; EC 3.2.1.20 (alpha-glucosidase) inhibitor; hepatoprotective agent; metabolite; radical scavenger |
2-[(2-ethoxyphenoxy)-phenylmethyl]morpholine | [no description available] | low | 0 | 0 | aromatic ether | |
naproxol | [no description available] | low | 0 | 0 | aromatic ether | antipyretic; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
tamoxifen n-oxide | [no description available] | low | 0 | 0 | aromatic ether; tertiary amine oxide | anti-estrogen; metabolite |
diafenthiuron | [no description available] | low | 0 | 0 | aromatic ether; thiourea acaricide; thiourea insecticide | oxidative phosphorylation inhibitor; proinsecticide |
ospemifene | [no description available] | low | 0 | 0 | aromatic ether; organochlorine compound; primary alcohol | anti-inflammatory agent; antineoplastic agent; estrogen receptor modulator |
tandutinib | [no description available] | low | 0 | 0 | aromatic ether; N-arylpiperazine; N-carbamoylpiperazine; phenylureas; piperidines; quinazolines; tertiary amino compound | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
zd 6474 | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound; organofluorine compound; piperidines; quinazolines; secondary amine | antineoplastic agent; tyrosine kinase inhibitor |
adefovir | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; biaryl; cyclic ketone; naphtho-gamma-pyrone; organooxygen heterocyclic antibiotic; polyphenol | antimalarial; Aspergillus metabolite; marine metabolite |
3-chloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
N-(2-hydroxyethyl)-4-[2-nitro-4-(trifluoromethyl)phenoxy]benzamide | [no description available] | low | 0 | 0 | aromatic ether | |
N'-[2-[(4-amino-5-cyano-2-pyrimidinyl)thio]-1-oxoethyl]-2-(4-methylphenoxy)acetohydrazide | [no description available] | low | 0 | 0 | aromatic ether | |
N-[(2-methyl-4-thiazolyl)methyl]-4-phenoxybenzenesulfonamide | [no description available] | low | 0 | 0 | aromatic ether | |
6-amino-4-(2-ethoxy-4-hydroxyphenyl)-3-propyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile | [no description available] | low | 0 | 0 | aromatic ether; pyranopyrazole | |
1-[(2-ethoxyphenyl)methyl]-3-thiophen-2-ylurea | [no description available] | low | 0 | 0 | aromatic ether | |
quinoxyfen | [no description available] | low | 0 | 0 | aromatic ether; monofluorobenzenes; organochlorine compound; quinolines | antifungal agrochemical |
nafadotride | [no description available] | low | 0 | 0 | aromatic ether; naphthalenecarboxamide; nitrile; pyrrolidines; tertiary amino compound | dopaminergic antagonist |
1-(1-naphthalenyl)-3-[[2-(2-nitrophenoxy)-1-oxoethyl]amino]urea | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
2-methyl-1,3-bis(phenylmethoxy)benzene | [no description available] | low | 0 | 0 | aromatic ether | |
1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethoxyphenoxysulfonyl)urea | [no description available] | low | 0 | 0 | aromatic ether | |
3-[(4-ethylphenoxy)methyl]-4-(6-methylheptan-2-yl)-1H-1,2,4-triazole-5-thione | [no description available] | low | 0 | 0 | aromatic ether | |
2-chloro-N-(2-methyl-6-oxo-5H-benzo[b][1,4]benzoxazepin-8-yl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
5-(benzenesulfonyl)-4-(2,6-dimethylphenoxy)-2-phenylpyrimidine | [no description available] | low | 0 | 0 | aromatic ether | |
4-(2-methylphenoxy)-6-phenylfuro[2,3-d]pyrimidine | [no description available] | low | 0 | 0 | aromatic ether | |
1-[4-(2-chlorophenoxy)butyl]imidazole | [no description available] | low | 0 | 0 | aromatic ether; imidazoles; monochlorobenzenes | |
N-(2-chlorophenyl)-4-[[(2-methoxy-4-nitroanilino)-sulfanylidenemethyl]hydrazo]-4-oxobutanamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
N-(2-methoxy-4-nitrophenyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound | |
N-[4-(phenoxymethyl)-2-thiazolyl]-1-adamantanecarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
hydroxypioglitazone | [no description available] | low | 0 | 0 | aromatic ether; pyridines; thiazolidinediones | human xenobiotic metabolite |
sc 560 | [no description available] | low | 0 | 0 | aromatic ether; monochlorobenzenes; organofluorine compound; pyrazoles | angiogenesis modulating agent; antineoplastic agent; apoptosis inducer; cyclooxygenase 1 inhibitor; non-steroidal anti-inflammatory drug |
sc-19220 | [no description available] | low | 0 | 0 | aromatic ether | |
5-methyl-4-(3-phenoxyphenyl)-2-sulfanylidene-3,4-dihydro-1H-pyrimidine-6-carboxylic acid ethyl ester | [no description available] | low | 0 | 0 | aromatic ether | |
8-[4-(4-fluorophenoxy)-3-nitrophenyl]-7-(2-hydroxyethyl)-3-(phenylmethyl)purine-2,6-dione | [no description available] | low | 0 | 0 | aromatic ether | |
2-phenoxybenzoic acid [2-oxo-2-(propan-2-ylamino)ethyl] ester | [no description available] | low | 0 | 0 | aromatic ether | |
2-(4-bromophenoxy)-N'-[2-[(4-methyl-1,2,4-triazol-3-yl)thio]-1-oxoethyl]acetohydrazide | [no description available] | low | 0 | 0 | aromatic ether | |
2-(2-methoxyanilino)-2-(2-phenylmethoxyphenyl)acetonitrile | [no description available] | low | 0 | 0 | aromatic ether; substituted aniline | |
N-(4-phenoxyphenyl)-2-(1,2,3,4-tetrahydroisoquinolin-1-yl)acetamide | [no description available] | low | 0 | 0 | aromatic ether | |
5-(3,4-dimethoxyphenyl)-3-(2-furanylmethyl)-4-imino-5H-[1]benzopyrano[2,3-d]pyrimidin-8-ol | [no description available] | low | 0 | 0 | aromatic ether | |
3,3-dimethyl-1,5-dinitro-6-phenoxy-3-azoniabicyclo[3.3.1]non-6-ene | [no description available] | low | 0 | 0 | aromatic ether | |
fraxin | [no description available] | low | 0 | 0 | aromatic ether; beta-D-glucoside; hydroxycoumarin | anti-inflammatory agent; hepatoprotective agent; plant metabolite |
fraxetin | [no description available] | low | 0 | 0 | aromatic ether; hydroxycoumarin | anti-inflammatory agent; antibacterial agent; antimicrobial agent; antioxidant; apoptosis inducer; apoptosis inhibitor; Arabidopsis thaliana metabolite; hepatoprotective agent; hypoglycemic agent |
5,6-dehydrokawain | [no description available] | low | 0 | 0 | 2-pyranones; aromatic ether | |
jtk-303 | [no description available] | low | 0 | 0 | aromatic ether; monochlorobenzenes; organofluorine compound; quinolinemonocarboxylic acid; quinolone | HIV-1 integrase inhibitor |
coniferin | [no description available] | low | 0 | 0 | aromatic ether; cinnamyl alcohol beta-D-glucoside; monosaccharide derivative | plant metabolite |
daphnoretin | [no description available] | low | 0 | 0 | aromatic ether; hydroxycoumarin | antineoplastic agent; antiviral agent; metabolite |
kavain | [no description available] | low | 0 | 0 | 2-pyranones; aromatic ether | |
methysticin | [no description available] | low | 0 | 0 | 2-pyranones; aromatic ether | |
yangonin | [no description available] | low | 0 | 0 | 2-pyranones; aromatic ether | |
hinokiflavone | [no description available] | low | 0 | 0 | aromatic ether; biflavonoid; hydroxyflavone | antineoplastic agent; metabolite; neuroprotective agent |
gentiacaulein | [no description available] | low | 0 | 0 | aromatic ether; polyphenol; xanthones | plant metabolite |
gentisin | [no description available] | low | 0 | 0 | aromatic ether; polyphenol; xanthones | plant metabolite |
isogentisin | [no description available] | low | 0 | 0 | aromatic ether; polyphenol; xanthones | EC 1.4.3.4 (monoamine oxidase) inhibitor; plant metabolite |
mangostin | [no description available] | low | 0 | 0 | aromatic ether; phenols; xanthones | antimicrobial agent; antineoplastic agent; antioxidant; plant metabolite |
1,8-dihydroxy-3,7-dimethoxyxanthone | [no description available] | low | 0 | 0 | aromatic ether; polyphenol; xanthones | plant metabolite |
swerchirin | [no description available] | low | 0 | 0 | aromatic ether; phenols; xanthones | hypoglycemic agent; metabolite |
1,2,8-trihydroxy-6-methoxyxanthone | [no description available] | low | 0 | 0 | aromatic ether; polyphenol; xanthones | antioxidant; plant metabolite |
wedelolactone | [no description available] | low | 0 | 0 | aromatic ether; coumestans; delta-lactone; polyphenol | antineoplastic agent; apoptosis inducer; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; hepatoprotective agent; metabolite |
cyhalothrin | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound | agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide |
sofalcone | [no description available] | low | 0 | 0 | aromatic ether; chalcones; monocarboxylic acid | anti-ulcer drug; antibacterial agent; gastrointestinal drug; plant metabolite |
neticonazole | [no description available] | low | 0 | 0 | aromatic ether; benzenes; conazole antifungal drug; enamine; imidazole antifungal drug; imidazoles; methyl sulfide | antifungal drug; EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor |
pibutidine | [no description available] | low | 0 | 0 | aromatic ether; cyclobutenones; olefinic compound; piperidines; primary amino compound; pyridines; secondary amino compound | anti-ulcer drug; H2-receptor antagonist |
purmorphamine | [no description available] | low | 0 | 0 | aromatic ether; morpholines; purines; secondary amino compound | osteogenesis regulator; SMO receptor agonist |
8-(2-chlorophenyl)-3-(4-ethoxyphenyl)-6-oxo-2,4,7,8-tetrahydropyrido[2,1-b][1,3,5]thiadiazine-9-carbonitrile | [no description available] | low | 0 | 0 | aromatic ether | |
ro 41-5253 | [no description available] | low | 0 | 0 | aromatic ether; benzoic acids; sulfone; thiochromane | apoptosis inducer; retinoic acid receptor alpha antagonist |
isoginkgetin | [no description available] | low | 0 | 0 | aromatic ether; biflavonoid | antineoplastic agent; EC 3.4.24.35 (gelatinase B) inhibitor; plant metabolite |
neoglycyrol | [no description available] | low | 0 | 0 | aromatic ether; coumestans; delta-lactone; polyphenol | antineoplastic agent; plant metabolite |
rhamnazin | [no description available] | low | 0 | 0 | aromatic ether; dimethoxyflavone; phenols; trihydroxyflavone | antineoplastic agent; plant metabolite |
bosutinib | [no description available] | low | 0 | 0 | aminoquinoline; aromatic ether; dichlorobenzene; N-methylpiperazine; nitrile; tertiary amino compound | antineoplastic agent; tyrosine kinase inhibitor |
bw b70c | [no description available] | low | 0 | 0 | aromatic ether; hydroxamic acid; organofluorine compound; ureas | EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor |
lichexanthone | [no description available] | low | 0 | 0 | aromatic ether; phenols; xanthones | plant metabolite |
alternariol monomethyl ether | [no description available] | low | 0 | 0 | aromatic ether; benzochromenone | antifungal agent; fungal metabolite; mycotoxin |
decussatin | [no description available] | low | 0 | 0 | aromatic ether; phenols; xanthones | plant metabolite |
bedaquiline | [no description available] | low | 0 | 0 | aromatic ether; naphthalenes; organobromine compound; quinolines; tertiary alcohol; tertiary amino compound | antitubercular agent; ATP synthase inhibitor |
dimethomorph | [no description available] | low | 0 | 0 | aromatic ether; enamide; monochlorobenzenes; morpholine fungicide; tertiary carboxamide | |
benanomicin b | [no description available] | low | 0 | 0 | aromatic ether; disaccharide derivative; L-alanine derivative; polyketide; polyphenol; pradimicin; secondary alcohol | |
pradimicin b | [no description available] | low | 0 | 0 | aromatic ether; L-alanine derivative; monosaccharide derivative; polyketide; polyphenol; pradimicin; secondary alcohol | |
1,7-dihydroxy-4-methoxyxanthone | [no description available] | low | 0 | 0 | aromatic ether; phenols; xanthones | metabolite; plant metabolite |
pradimicin a | [no description available] | low | 0 | 0 | aromatic ether; carboxylic acid; disaccharide derivative; L-alanine derivative; p-quinones; polyphenol; pradimicin; secondary alcohol | |
clodinafop | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound; pyridines | EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; phenoxy herbicide |
ici 118551 | [no description available] | low | 0 | 0 | aromatic ether; indanes; secondary alcohol; secondary amino compound | beta-adrenergic antagonist |
ochnaflavone | [no description available] | low | 0 | 0 | aromatic ether; biflavonoid; hydroxyflavone | anti-inflammatory agent; antiatherogenic agent; antibacterial agent; EC 3.1.1.4 (phospholipase A2) inhibitor; leukotriene antagonist; plant metabolite |
3-(4-fluorophenoxy)-6-methoxy-2-(4-methoxyphenyl)-1-benzothiophene 1-oxide | [no description available] | low | 0 | 0 | aromatic ether | |
flavasperone | [no description available] | low | 0 | 0 | aromatic ether; naphtho-gamma-pyrone; phenols | acyl-CoA:cholesterol acyltransferase 2 inhibitor; antiviral agent; Aspergillus metabolite; marine metabolite |
4-hydroxycordoin | [no description available] | low | 0 | 0 | aromatic ether; chalcones; polyphenol | anti-inflammatory agent; antibacterial agent; plant metabolite |
n-feruloylserotonin | [no description available] | low | 0 | 0 | aromatic ether; cinnamamides; hydroxyindoles; phenols; secondary carboxamide | plant metabolite |
tyrphostin ag825 | [no description available] | low | 0 | 0 | aromatic ether; benzothiazoles; enamide; nitrile; organic sulfide; phenols; primary carboxamide | epidermal growth factor receptor antagonist |
kresoxim-methyl | [no description available] | low | 0 | 0 | aromatic ether; methoxyiminoacetate strobilurin antifungal agent; methyl ester; oxime O-ether | antifungal agrochemical; environmental contaminant; mitochondrial cytochrome-bc1 complex inhibitor; xenobiotic |
5-methoxy-3,6-diphenyl-1,2,4-triazine | [no description available] | low | 0 | 0 | aromatic ether | |
pyrachlostrobin | [no description available] | low | 0 | 0 | aromatic ether; carbamate ester; carbanilate fungicide; methoxycarbanilate strobilurin antifungal agent; monochlorobenzenes; pyrazoles | antifungal agrochemical; environmental contaminant; mitochondrial cytochrome-bc1 complex inhibitor; xenobiotic |
piericidin a | [no description available] | low | 0 | 0 | aromatic ether; methylpyridines; monohydroxypyridine; secondary allylic alcohol | antimicrobial agent; bacterial metabolite; EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor; mitochondrial respiratory-chain inhibitor |
metrafenone | [no description available] | low | 0 | 0 | aromatic ether; aryl phenyl ketone fungicide; benzophenones; organobromine compound | antifungal agrochemical |
2-(4-fluoro-3-(trifluoromethyl)phenoxy)-n-(phenylmethyl)butanamide | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; monocarboxylic acid amide; monofluorobenzenes | |
b 43 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; cyclopentanes; primary amino compound; pyrrolopyrimidine | EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector |
5-(4-phenylbutoxy)psoralen | [no description available] | low | 0 | 0 | aromatic ether; benzenes; psoralens | geroprotector; immunosuppressive agent; potassium channel blocker |
5-ia-85380 | [no description available] | low | 0 | 0 | aromatic ether | |
yunaconitine | [no description available] | low | 0 | 0 | acetate ester; aromatic ether; benzoate ester; bridged compound; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary alcohol; tertiary amino compound | antifeedant; human urinary metabolite; phytotoxin; plant metabolite; xenobiotic |
ru 58668 | [no description available] | low | 0 | 0 | 17beta-hydroxy steroid; 3-hydroxy steroid; aromatic ether; organofluorine compound; sulfone | anti-estrogen; antineoplastic agent; estrogen receptor antagonist |
altenusin | [no description available] | low | 0 | 0 | aromatic ether; carboxybiphenyl; catechols; hydroxybiphenyls; polyphenol | antifungal agent; fungal metabolite |
gw 501516 | [no description available] | low | 0 | 0 | 1,3-thiazoles; aromatic ether; aryl sulfide; monocarboxylic acid; organofluorine compound | carcinogenic agent; PPARbeta/delta agonist |
bay 58-2667 | [no description available] | low | 0 | 0 | aromatic ether; benzoic acids; dicarboxylic acid; tertiary amino compound | antihypertensive agent; soluble guanylate cyclase activator; vasodilator agent |
camostat | [no description available] | low | 0 | 0 | aromatic ether; phenols | |
lenvatinib | [no description available] | low | 0 | 0 | aromatic amide; aromatic ether; cyclopropanes; monocarboxylic acid amide; monochlorobenzenes; phenylureas; quinolines | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist; orphan drug; vascular endothelial growth factor receptor antagonist |
nsc 716970 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; indolecarboxamide; organochlorine compound | antineoplastic agent |
lobeglitazone | [no description available] | low | 0 | 0 | aromatic ether | |
noviflumuron | [no description available] | low | 0 | 0 | aromatic ether; benzoylurea insecticide; dichlorobenzene; organofluorine compound | |
etomoxir | [no description available] | low | 0 | 0 | aromatic ether | |
fr 148083 | [no description available] | low | 0 | 0 | aromatic ether; macrolide; phenols; secondary alcohol; secondary alpha-hydroxy ketone | antibacterial agent; antineoplastic agent; metabolite; NF-kappaB inhibitor |
9-methoxycanthin-6-one | [no description available] | low | 0 | 0 | aromatic ether; indole alkaloid; organic heterotetracyclic compound | antineoplastic agent; antiplasmodial drug; metabolite |
sb 3ct compound | [no description available] | low | 0 | 0 | aromatic ether | |
varespladib methyl | [no description available] | low | 0 | 0 | aromatic ether; benzenes; indoles; methyl ester; primary carboxamide | anti-inflammatory drug; antidote; EC 3.1.1.4 (phospholipase A2) inhibitor; prodrug |
dapagliflozin | [no description available] | low | 0 | 0 | aromatic ether; C-glycosyl compound; monochlorobenzenes | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor |
naveglitazar | [no description available] | low | 0 | 0 | aromatic ether | |
tivozanib | [no description available] | low | 0 | 0 | aromatic ether | |
zm 447439 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; morpholines; polyether; quinazolines; secondary amino compound; tertiary amino compound | antineoplastic agent; apoptosis inducer; Aurora kinase inhibitor |
ustiloxin b | [no description available] | low | 0 | 0 | aromatic ether; heterodetic cyclic peptide; macrocycle; phenols; secondary alcohol; secondary carboxamide; sulfoxide | Aspergillus metabolite; microtubule-destabilising agent; mycotoxin |
hypothemycin | [no description available] | low | 0 | 0 | aromatic ether; diol; enone; epoxide; macrolide; phenols; polyketide; secondary alpha-hydroxy ketone | antifungal agent; antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; fungal metabolite |
tryprostatin a | [no description available] | low | 0 | 0 | aromatic ether; dipeptide; indole alkaloid; indoles; pyrrolopyrazine | breast cancer resistance protein inhibitor |
cediranib | [no description available] | low | 0 | 0 | aromatic ether | |
3-iodothyronamine | [no description available] | low | 0 | 0 | aromatic ether | |
n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride | [no description available] | low | 0 | 0 | aromatic ether; hydrochloride; methoxybenzenes; tertiary amino compound | antipsychotic agent; receptor modulator |
rubraxanthone | [no description available] | low | 0 | 0 | aromatic ether; polyphenol; xanthones | antibacterial agent; antineoplastic agent; metabolite |
7,8-Dihydroyangonin | [no description available] | low | 0 | 0 | 2-pyranones; aromatic ether | |
sch 51344 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; primary alcohol; pyrazoloquinoline; secondary amino compound | antineoplastic agent |
ancistroealaine a | [no description available] | low | 0 | 0 | aromatic ether; biaryl; isoquinoline alkaloid; isoquinolines; methoxynaphthalene; methylnaphthalenes | antileishmanial agent; antiplasmodial drug; metabolite; trypanocidal drug |
pimavanserin | [no description available] | low | 0 | 0 | aromatic ether; monofluorobenzenes; piperidines; tertiary amino compound; ureas | 5-hydroxytryptamine 2A receptor inverse agonist; antipsychotic agent; serotonergic antagonist |
tolfenpyrad | [no description available] | low | 0 | 0 | aromatic amide; aromatic ether; organochlorine compound; pyrazole insecticide | agrochemical; antifungal agent; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mitochondrial NADH:ubiquinone reductase inhibitor |
SIS3 free base | [no description available] | low | 0 | 0 | aromatic ether; enamide; isoquinolines; monocarboxylic acid amide; pyrrolopyridine; tertiary carboxamide | Smad3 inhibitor |
apixaban | [no description available] | low | 0 | 0 | aromatic ether; lactam; piperidones; pyrazolopyridine | anticoagulant; EC 3.4.21.6 (coagulation factor Xa) inhibitor |
bibw 2992 | [no description available] | low | 0 | 0 | aromatic ether; enamide; furans; monochlorobenzenes; organofluorine compound; quinazolines; secondary carboxamide; tertiary amino compound | antineoplastic agent; tyrosine kinase inhibitor |
dihydrokavain | [no description available] | low | 0 | 0 | 2-pyranones; aromatic ether | |
troglitazone sulfate | [no description available] | low | 0 | 0 | aromatic ether; thiazolidinone | |
arisugacin | [no description available] | low | 0 | 0 | aromatic ether; delta-lactone; enone; organic heterotetracyclic compound; tertiary alcohol | antimicrobial agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; metabolite; Penicillium metabolite |
saracatinib | [no description available] | low | 0 | 0 | aromatic ether; benzodioxoles; diether; N-methylpiperazine; organochlorine compound; oxanes; quinazolines; secondary amino compound | anticoronaviral agent; antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; radiosensitizing agent |
fonsecinone a | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; biaryl; cyclic ketone; naphtho-gamma-pyrone; polyphenol | antibacterial agent; Aspergillus metabolite |
crenolanib | [no description available] | low | 0 | 0 | aminopiperidine; aromatic ether; benzimidazoles; oxetanes; quinolines; tertiary amino compound | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
aiphanol | [no description available] | low | 0 | 0 | aromatic ether; benzodioxine; lignan; stilbenoid | EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor |
nigerloxin | [no description available] | low | 0 | 0 | aromatic ether; benzamides; benzoic acids; phenols; styrenes | antioxidant; Aspergillus metabolite; EC 1.1.1.21 (aldehyde reductase) inhibitor; lipoxygenase inhibitor; radical scavenger |
msdc-0160 | [no description available] | low | 0 | 0 | aromatic ether | |
dihydroxanthohumol | [no description available] | low | 0 | 0 | aromatic ether; dihydrochalcones; polyphenol | EC 1.14.13.39 (nitric oxide synthase) inhibitor; metabolite |
PB28 | [no description available] | low | 0 | 0 | aromatic ether; piperazines; tetralins | anticoronaviral agent; antineoplastic agent; apoptosis inducer; sigma-2 receptor agonist |
7-phloroeckol | [no description available] | low | 0 | 0 | aromatic ether; phlorotannin | antioxidant; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; metabolite |
3,5-dimethoxy-4-hydroxybenzyl alcohol-4-O-beta-D-glucopyranoside | [no description available] | low | 0 | 0 | aromatic ether; benzyl alcohols; beta-D-glucoside; monosaccharide derivative; primary alcohol | antineoplastic agent; metabolite |
PDGF receptor tyrosine kinase inhibitor III | [no description available] | low | 0 | 0 | aromatic ether; N-arylpiperazine; N-carbamoylpiperazine; phenylureas; quinazolines; tertiary amino compound | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
fluoxastrobin | [no description available] | low | 0 | 0 | aromatic ether; dioxazine; monochlorobenzenes; organofluorine compound; oxime O-ether; pyrimidines; strobilurin antifungal agent | antifungal agrochemical; mitochondrial cytochrome-bc1 complex inhibitor |
flumorph | [no description available] | low | 0 | 0 | aromatic ether; enamide; morpholines; organofluorine compound; tertiary carboxamide | |
regorafenib | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; monofluorobenzenes; phenylureas; pyridinecarboxamide | antineoplastic agent; hepatotoxic agent; tyrosine kinase inhibitor |
erastin | [no description available] | low | 0 | 0 | aromatic ether; diether; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; quinazolines; tertiary carboxamide | antineoplastic agent; ferroptosis inducer; voltage-dependent anion channel inhibitor |
brivanib | [no description available] | low | 0 | 0 | aromatic ether; diether; fluoroindole; pyrrolotriazine; secondary alcohol | angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; drug metabolite; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist |
fg-4592 | [no description available] | low | 0 | 0 | aromatic ether; isoquinolines; N-acylglycine | EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor |
picoxystrobin | [no description available] | low | 0 | 0 | aromatic ether; enoate ester; enol ether; methoxyacrylate strobilurin antifungal agent; organofluorine compound; pyridines | antifungal agrochemical; mitochondrial cytochrome-bc1 complex inhibitor |
cenicriviroc | [no description available] | low | 0 | 0 | aromatic ether; benzazocine; diether; imidazoles; secondary carboxamide; sulfoxide | anti-HIV agent; anti-inflammatory agent; antirheumatic drug; chemokine receptor 2 antagonist; chemokine receptor 5 antagonist |
mandipropamid | [no description available] | low | 0 | 0 | aromatic ether; monocarboxylic acid amide; monochlorobenzenes; terminal acetylenic compound | |
glyceryl ferulate | [no description available] | low | 0 | 0 | 1-monoglyceride; aromatic ether; enoate ester; phenols | antioxidant; plant metabolite; ultraviolet filter |
ki 8751 | [no description available] | low | 0 | 0 | aromatic ether | |
ceratamine a | [no description available] | low | 0 | 0 | alkaloid; aromatic ether; cyclic ketone; organic heterobicyclic compound; organobromine compound; secondary amino compound; tertiary amine | antimitotic; metabolite |
azd 8931 | [no description available] | low | 0 | 0 | aromatic ether; monochlorobenzenes; monofluorobenzenes; piperidines; quinazolines; secondary amino compound; tertiary amino compound | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; epidermal growth factor receptor antagonist |
bay94 9172 | [no description available] | low | 0 | 0 | (18)F radiopharmaceutical; aromatic ether; polyether; secondary amino compound; stilbenoid; substituted aniline | radioactive imaging agent |
olodaterol | [no description available] | low | 0 | 0 | aromatic ether; benzoxazine; phenols; secondary alcohol; secondary amino compound | beta-adrenergic agonist; bronchodilator agent |
dorsomorphin | [no description available] | low | 0 | 0 | aromatic ether; piperidines; pyrazolopyrimidine; pyridines | bone morphogenetic protein receptor antagonist; EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor |
cj-042794 | [no description available] | low | 0 | 0 | aromatic ether | |
hu 308 | [no description available] | low | 0 | 0 | aromatic ether; bridged compound; carbobicyclic compound; primary allylic alcohol; synthetic cannabinoid | anti-inflammatory agent; antihypertensive agent; apoptosis inhibitor; bone density conservation agent; CB2 receptor agonist |
ki11502 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; quinolines; thioureas | antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
apremilast | [no description available] | low | 0 | 0 | aromatic ether; N-acetylarylamine; phthalimides; sulfone | non-steroidal anti-inflammatory drug; phosphodiesterase IV inhibitor |
PF-00835231 | [no description available] | low | 0 | 0 | aromatic ether; indolecarboxamide; L-leucine derivative; primary alcohol; pyrrolidin-2-ones; secondary carboxamide | anticoronaviral agent; drug metabolite; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor |
3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; dichlorobenzene; organofluorine compound; pyrazolylpiperidine; racemate | antineoplastic agent; biomarker; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
chir-265 | [no description available] | low | 0 | 0 | aromatic ether | |
aminocandin | [no description available] | low | 0 | 0 | aromatic ether; echinocandin; homodetic cyclic peptide | antiinfective agent |
zk 756326 | [no description available] | low | 0 | 0 | aromatic ether | |
bay 60-6583 | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; aryl sulfide; cyanopyridine; cyclopropanes; monocarboxylic acid amide | adenosine A2B receptor agonist; anti-inflammatory agent; cardioprotective agent |
empagliflozin | [no description available] | low | 0 | 0 | aromatic ether; C-glycosyl compound; monochlorobenzenes; tetrahydrofuryl ether | hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor |
4-[5-(4-ethoxyphenyl)-3-isoxazolyl]-N-[(4-methylphenyl)methyl]butanamide | [no description available] | low | 0 | 0 | aromatic ether | |
bgt226 | [no description available] | low | 0 | 0 | aromatic ether; imidazoquinoline; N-arylpiperazine; organofluorine compound; pyridines | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor |
n-desmethylrosiglitazone | [no description available] | low | 0 | 0 | aromatic ether | |
4-(5-methyl-3-nitro-1-pyrazolyl)-N-[3-(4-methylphenoxy)-5-nitrophenyl]butanamide | [no description available] | low | 0 | 0 | aromatic ether | |
verruculogen | [no description available] | low | 0 | 0 | aromatic ether; diol; indole alkaloid; organic heterohexacyclic compound; organic peroxide | Aspergillus metabolite; GABA modulator; mycotoxin; Penicillium metabolite; potassium channel blocker |
1-O-feruloyl-beta-D-glucose | [no description available] | low | 0 | 0 | aromatic ether; beta-D-glucoside; cinnamate ester; phenols | antioxidant; plant metabolite |
2,2',4,5'-tetrabromodiphenyl ether | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound | |
hexabromodiphenyl ether 154 | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound | |
bde 183 | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound | |
l-798106 | [no description available] | low | 0 | 0 | aromatic ether; bromobenzenes; N-sulfonylcarboxamide | prostaglandin receptor antagonist |
aflatoxin m1 | [no description available] | low | 0 | 0 | aflatoxin; aromatic ether; aromatic ketone; tertiary alcohol | Aspergillus metabolite; human xenobiotic metabolite; mammalian metabolite |
macitentan | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound; pyrimidines; ring assembly; sulfamides | antihypertensive agent; endothelin receptor antagonist; orphan drug |
CDN1163 | [no description available] | low | 0 | 0 | aromatic ether; quinolines; secondary carboxamide | SERCA activator |
e 7050 | [no description available] | low | 0 | 0 | aromatic ether | |
N-[(5-chloro-2-thiophenyl)methyl]-5-[(2,6-difluorophenoxy)methyl]-3-isoxazolecarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
dafadine C | [no description available] | low | 0 | 0 | aromatic amide; aromatic ether; difluorobenzene; isoxazoles; N-acylpiperidine; pyridines | P450 inhibitor |
dafadine B | [no description available] | low | 0 | 0 | aromatic amide; aromatic ether; isoxazoles; monochlorobenzenes; monofluorobenzenes; N-acylpiperidine; pyridines | P450 inhibitor |
3-[5-(5-methyl-2-thiophenyl)-1,3,4-oxadiazol-2-yl]-N-[2-(3-pyridinyloxy)propyl]propanamide | [no description available] | low | 0 | 0 | aromatic ether | |
violaceol II | [no description available] | low | 0 | 0 | aromatic ether; catechols; resorcinols | mycotoxin |
pamapimod | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; difluorobenzene; diol; primary alcohol; pyridopyrimidine; secondary amino compound | antirheumatic drug; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
gsk690693 | [no description available] | low | 0 | 0 | 1,2,5-oxadiazole; acetylenic compound; aromatic amine; aromatic ether; imidazopyridine; piperidines; primary amino compound; tertiary alcohol | antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
cnf 2024 | [no description available] | low | 0 | 0 | 2-aminopurines; aromatic ether; organochlorine compound; pyridines | antineoplastic agent; Hsp90 inhibitor |
uk 453,061 | [no description available] | low | 0 | 0 | aromatic ether | |
zm323881 | [no description available] | low | 0 | 0 | aromatic ether; benzyl ether; fluorophenol; halophenol; monofluorobenzenes; organic cation; quinazolines; secondary amino compound; substituted aniline | vascular endothelial growth factor receptor antagonist |
compound w | [no description available] | low | 0 | 0 | aromatic ether | |
2-[[4-[2-[(2-methylpropan-2-yl)oxy]anilino]-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | [no description available] | low | 0 | 0 | aromatic ether | |
interiotherin b | [no description available] | low | 0 | 0 | aromatic ether; fatty acid ester; lignan; organic heteropentacyclic compound; oxacycle | anti-HIV agent; metabolite |
5,7-dihydroxy-3-(3-hydroxy-4-methoxybenzyl)-6-methoxychroman-4-one | [no description available] | low | 0 | 0 | aromatic ether; homoisoflavonoid; polyphenol | angiogenesis modulating agent; plant metabolite |
ph 797804 | [no description available] | low | 0 | 0 | aromatic ether; benzamides; organobromine compound; organofluorine compound; pyridone | anti-inflammatory agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
diorcinol | [no description available] | low | 0 | 0 | aromatic ether; phenols | fungal metabolite; marine metabolite; metabolite |
2-[[4-(2-phenoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | [no description available] | low | 0 | 0 | aromatic ether | |
2-[[4-(1-pyrrolidinyl)-6-[2-(trifluoromethoxy)anilino]-1,3,5-triazin-2-yl]amino]ethanol | [no description available] | low | 0 | 0 | aromatic ether | |
2-[[4-(5-chloro-2-ethoxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | [no description available] | low | 0 | 0 | aromatic ether | |
2-[[4-(5-chloro-2-propan-2-yloxyanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol | [no description available] | low | 0 | 0 | aromatic ether | |
mk 5108 | [no description available] | low | 0 | 0 | aromatic ether | |
lde225 | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; benzamides; biphenyls; morpholines; organofluorine compound; tertiary amino compound | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist |
1-azepanyl-[5-[(4-chloro-3,5-dimethylphenoxy)methyl]-3-isoxazolyl]methanone | [no description available] | low | 0 | 0 | aromatic ether | |
4-(1-((5-((2,6-dimethylphenoxy)methyl)-3-isoxazolyl)carbonyl)-4-piperidinyl)pyridine | [no description available] | low | 0 | 0 | aromatic amide; aromatic ether; isoxazoles; N-acylpiperidine; pyridines | geroprotector; P450 inhibitor |
dafadine D | [no description available] | low | 0 | 0 | aromatic amide; aromatic ether; isoxazoles; N-acylpiperidine; organofluorine compound; pyridines | P450 inhibitor |
1-[(1-ethyl-3-methyl-4-pyrazolyl)methyl]-N-[4-(2-fluorophenoxy)phenyl]-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
dafadine O | [no description available] | low | 0 | 0 | aromatic amide; aromatic ether; isoxazoles; N-acylpiperidine; pyridines; ring assembly | P450 inhibitor |
5-[(3,4-dimethylphenoxy)methyl]-N-methyl-N-(4-oxanylmethyl)-3-isoxazolecarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
pci 32765 | [no description available] | low | 0 | 0 | acrylamides; aromatic amine; aromatic ether; N-acylpiperidine; pyrazolopyrimidine; tertiary carboxamide | antineoplastic agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
florbetapir f 18 | [no description available] | low | 0 | 0 | (18)F radiopharmaceutical; aromatic ether; organofluorine compound; pyridines; substituted aniline | radioactive imaging agent |
AMG-208 | [no description available] | low | 0 | 0 | aromatic ether; quinolines; triazolopyridazine | antineoplastic agent; c-Met tyrosine kinase inhibitor |
6-methoxyspirotryprostatin b | [no description available] | low | 0 | 0 | aromatic ether; azaspiro compound; indole alkaloid; indolones | antineoplastic agent; Aspergillus metabolite |
lucitanib | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanes; naphthalenecarboxamide; primary amino compound; quinolines | antineoplastic agent; fibroblast growth factor receptor antagonist; vascular endothelial growth factor receptor antagonist |
act-132577 | [no description available] | low | 0 | 0 | aromatic ether; organobromine compound; pyrimidines; sulfamides | antihypertensive agent; drug metabolite; endothelin receptor antagonist; xenobiotic metabolite |
cabozantinib | [no description available] | low | 0 | 0 | aromatic ether; dicarboxylic acid diamide; organofluorine compound; quinolines | antineoplastic agent; tyrosine kinase inhibitor |
poziotinib | [no description available] | low | 0 | 0 | acrylamides; aromatic ether; dichlorobenzene; diether; monofluorobenzenes; N-acylpiperidine; quinazolines; secondary amino compound; substituted aniline | antineoplastic agent; apoptosis inducer; epidermal growth factor receptor antagonist |
gsk 2126458 | [no description available] | low | 0 | 0 | aromatic ether; difluorobenzene; pyridazines; pyridines; quinolines; sulfonamide | anticoronaviral agent; antineoplastic agent; autophagy inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor; radiosensitizing agent |
gsk 1363089 | [no description available] | low | 0 | 0 | aromatic ether | |
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-propan-2-ylurea | [no description available] | low | 0 | 0 | aromatic ether | |
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-propan-2-ylurea | [no description available] | low | 0 | 0 | aromatic ether | |
3-cyclohexyl-1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | [no description available] | low | 0 | 0 | aromatic ether | |
3-cyclohexyl-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-(propan-2-ylamino)methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | [no description available] | low | 0 | 0 | aromatic ether | |
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | aromatic ether | |
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea | [no description available] | low | 0 | 0 | aromatic ether | |
monepantel | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; aryl sulfide; nitrile; secondary carboxamide | anthelminthic drug; nematicide |
an2728 | [no description available] | low | 0 | 0 | aromatic ether; benzoxaborole; nitrile | antipsoriatic; non-steroidal anti-inflammatory drug; phosphodiesterase IV inhibitor |
grazoprevir | [no description available] | low | 0 | 0 | aromatic ether; azamacrocycle; carbamate ester; cyclopropanes; lactam; N-sulfonylcarboxamide; quinoxaline derivative | antiviral drug; hepatitis C protease inhibitor; hepatoprotective agent |
hordatine a | [no description available] | low | 0 | 0 | aromatic ether; benzofurans; dicarboxylic acid diamide; guanidines; phenols | adrenergic antagonist; metabolite |
5-chloro-2-(3,5-dimethylphenyl)-4-(4-methoxyphenoxy)-3-pyridazinone | [no description available] | low | 0 | 0 | aromatic ether | |
tak-632 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; benzothiazoles; cyclopropylcarboxamide; monofluorobenzenes; nitrile; secondary carboxamide | antineoplastic agent; apoptosis inducer; B-Raf inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor; necroptosis inhibitor |
lrrk2-in1 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; N-acylpiperidine; N-alkylpiperazine; pyrimidobenzodiazepine; secondary amino compound; tertiary amino compound | antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
quinolobactin | [no description available] | low | 0 | 0 | aromatic ether; monohydroxyquinoline; phenols; quinolinemonocarboxylic acid | bacterial metabolite; siderophore |
AZD1979 | [no description available] | low | 0 | 0 | aromatic ether; azaspiro compound; carboxamide; N-acylazetidine; oxadiazole; oxaspiro compound; oxetanes | melanin-concentrating hormone receptor antagonist |
ML240 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; benzimidazoles; primary amino compound; quinazolines; secondary amino compound | antineoplastic agent |
aripiprazole lauroxil | [no description available] | low | 0 | 0 | aromatic ether; delta-lactam; dichlorobenzene; dodecanoate ester; N-alkylpiperazine; N-arylpiperazine; quinolone | H1-receptor antagonist; prodrug; second generation antipsychotic; serotonergic agonist |
abt-199 | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine | antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor |
xl765 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; benzamides; quinoxaline derivative; sulfonamide | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor |
DMH1 | [no description available] | low | 0 | 0 | aromatic ether; pyrazolopyrimidine; quinolines | antineoplastic agent; bone morphogenetic protein receptor antagonist; protein kinase inhibitor |
2-methoxy-N-[3-[4-[3-methyl-4-[(6-methyl-3-pyridinyl)oxy]anilino]-6-quinazolinyl]prop-2-enyl]acetamide | [no description available] | low | 0 | 0 | aromatic ether; methylpyridines; olefinic compound; quinazolines; secondary amino compound; secondary carboxamide; toluenes | |
pf 4800567 | [no description available] | low | 0 | 0 | aromatic ether; monochlorobenzenes; oxanes; pyrazolopyrimidine | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
propenylphosphonic acid | [no description available] | low | 0 | 0 | aromatic ether | |
abt-333 | [no description available] | low | 0 | 0 | aromatic ether; naphthalenes; pyrimidone; sulfonamide | antiviral drug; nonnucleoside hepatitis C virus polymerase inhibitor |
naloxegol | [no description available] | low | 0 | 0 | aromatic ether; organic heteropentacyclic compound; phenols; polyether; tertiary alcohol | cathartic; mu-opioid receptor antagonist |
ceritinib | [no description available] | low | 0 | 0 | aminopyrimidine; aromatic ether; organochlorine compound; piperidines; secondary amino compound; sulfone | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
MK-8353 | [no description available] | low | 0 | 0 | aromatic ether; dihydropyridine; indazoles; methyl sulfide; N-alkylpyrrolidine; pyridines; pyrrolidinecarboxamide; secondary carboxamide; tertiary carboxamide; triazoles | antineoplastic agent; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor |
HG-10-102-01 | [no description available] | low | 0 | 0 | aminopyrimidine; aromatic ether; monocarboxylic acid amide; morpholines; organochlorine compound; secondary amino compound | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
N-[(5-methyl-2-furanyl)methylideneamino]-2-phenoxybenzamide | [no description available] | low | 0 | 0 | aromatic ether | |
saroglitazar | [no description available] | low | 0 | 0 | aromatic ether; methyl sulfide; monocarboxylic acid; pyrroles | hypoglycemic agent; PPARalpha agonist; PPARgamma agonist |
fertaric acid | [no description available] | low | 0 | 0 | aromatic ether; cinnamate ester; dicarboxylic acid; phenols; tetraric acid derivative | |
2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; tertiary alcohol; triazoles | |
pf-06463922 | [no description available] | low | 0 | 0 | aminopyridine; aromatic ether; azamacrocycle; benzamides; cyclic ether; monofluorobenzenes; nitrile; organic heterotetracyclic compound; pyrazoles | antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
DDR1-IN-1 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; aromatic ether; benzamides; N-alkylpiperazine; oxindoles; secondary carboxamide | EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor |
ldc4297 | [no description available] | low | 0 | 0 | aromatic ether; piperidines; pyrazoles; pyrazolotriazine; secondary amino compound | antineoplastic agent; antiviral agent; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor |
MLI-2 | [no description available] | low | 0 | 0 | aromatic ether; cyclopropanes; indazoles; morpholines; pyrimidines; tertiary amino compound | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
ap20187 | [no description available] | low | 0 | 0 | aromatic ether; carboxylic ester; N-acylpiperidine; tertiary amino compound | ligand |
biliatresone | [no description available] | low | 0 | 0 | aromatic ether; aromatic ketone; benzodioxoles; enone; phenols | plant metabolite; toxin |
tak 491 | [no description available] | low | 0 | 0 | 1,2,4-oxadiazole; aromatic ether; benzimidazoles; carboxylic ester; cyclic carbonate ester; dioxolane | angiotensin receptor antagonist; antihypertensive agent; prodrug |
azilsartan | [no description available] | low | 0 | 0 | 1,2,4-oxadiazole; aromatic ether; benzimidazolecarboxylic acid | angiotensin receptor antagonist; antihypertensive agent |
hydrazinocurcumin | [no description available] | low | 0 | 0 | aromatic ether; olefinic compound; polyphenol; pyrazoles | angiogenesis modulating agent; antineoplastic agent; EC 2.3.1.48 (histone acetyltransferase) inhibitor; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
mirodenafil | [no description available] | low | 0 | 0 | aromatic ether; N-alkylpiperazine; primary alcohol; pyrrolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
cerulomycin | [no description available] | low | 0 | 0 | aldoxime; aromatic ether; bipyridines; pyridine alkaloid | antineoplastic agent; bacterial metabolite; marine metabolite |
undecylprodigiosin | [no description available] | low | 0 | 0 | alkaloid; aromatic ether; tripyrrole | antibacterial agent; antineoplastic agent; apoptosis inducer; bacterial metabolite; biological pigment; immunosuppressive agent; radiosensitizing agent |
sb-590885 | [no description available] | low | 0 | 0 | aromatic ether; imidazoles; ketoxime; pyridines; tertiary amino compound | |
2-[[4-(trifluoromethoxy)phenyl]methylthio]-1,5,6,7-tetrahydrocyclopenta[d]pyrimidin-4-one | [no description available] | low | 0 | 0 | aromatic ether | |
PF-07304814 | [no description available] | low | 0 | 0 | aromatic ether; indolecarboxamide; L-leucine derivative; phosphate monoester; pyrrolidin-2-ones; secondary carboxamide | anticoronaviral agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; prodrug |